{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:42:09Z","timestamp":1794336129708,"version":"4.9.0"},"reference-count":324,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. Genetic factors, and various environmental factors, including nutrition and the composition of the gut microbiota, have been identified as important factors in the initiation of CVD. Among them, the pivotal role of the gut microbiota in modulating cholesterol metabolism and influencing cardiovascular outcomes has recently been highlighted. Extensive research has confirmed that the gut microbiota has direct and indirect regulatory effects on host cholesterol homeostasis. Recent studies have shown that the microbiota can influence blood cholesterol levels and thus the risk of CVD through various pathways, such as the production of certain metabolites such as bile acids (BAs), SCFAs, and TMAO, the activation of nuclear and membrane-bound receptors such as farnesoid X receptor (FXR), the regulation of gene expression involved in lipid metabolism and inflammatory responses, as well as microbial enzymatic pathways. These complex regulatory mechanisms make the gut microbiota a potential therapeutic target in cholesterol-related diseases and CVD. Microbiota-modulating strategies, including the use of probiotics, prebiotics, fecal microbiota transplantation (FMT), and selective antibiotics, have shown beneficial effects in previous studies. In this regard, in this study, we conducted an in-depth investigation of the regulatory effect of intestinal microbiota on cholesterol metabolism and their impact on the development and progression of atherosclerosis and CVD, and described potential therapeutic pathways based on the regulation of intestinal microbiota in CVD.<\/jats:p>","DOI":"10.1186\/s12986-025-01051-7","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T02:24:23Z","timestamp":1764815063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gut microbiota\u2013cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammad","family":"Abavisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Ebadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Karav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"11","key":"1051_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","volume":"45","author":"L Nedkoff","year":"2023","unstructured":"Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023;45(11):1087\u201391.","journal-title":"Clin Ther"},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"155931","DOI":"10.1016\/j.prp.2025.155931","volume":"269","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Tafti P, Khoshroo N, Ebadpour N, Khoshrou A, Kesharwani P, et al. The heart of the matter: how gut microbiota-targeted interventions influence cardiovascular diseases. Pathol - Res Pract. 2025;269:155931.","journal-title":"Pathol - Res Pract"},{"key":"1051_CR3","first-page":"101189","volume":"16","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Ebadpour N, Khoshrou A, Sahebkar A. Boosting vaccine effectiveness: the groundbreaking role of probiotics. J Agric Food Res. 2024;16:101189.","journal-title":"J Agric Food Res"},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuroscience.2024.11.068","volume":"565","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Faraji N, Ebadpour N, Kesharwani P, Sahebkar A. Beyond digestion: exploring how the gut microbiota modulates human social behaviors. Neuroscience. 2025;565:52\u201362.","journal-title":"Neuroscience"},{"issue":"1","key":"1051_CR5","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1097\/j.pbj.0000000000000106","volume":"6","author":"C Almeida","year":"2021","unstructured":"Almeida C, Barata P, Fernandes R. The influence of gut microbiota in cardiovascular diseases-a brief review. Porto Biomed J. 2021;6(1):e106.","journal-title":"Porto Biomed J"},{"issue":"5","key":"1051_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","volume":"23","author":"DT Michaeli","year":"2023","unstructured":"Michaeli DT, Michaeli JC, Albers S, Boch T, Michaeli T. Established and emerging Lipid-Lowering drugs for primary and secondary cardiovascular prevention. Am J Cardiovasc Drugs. 2023;23(5):477\u201395.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"1051_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2013.06.019","volume":"35","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New LDL-cholesterol Lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082\u201398.","journal-title":"Clin Ther"},{"issue":"6","key":"1051_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","volume":"27","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New therapies targeting ApoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther. 2013;27(6):559\u201367.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"1051_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4093\/dmj.2022.0198","volume":"46","author":"K Kim","year":"2022","unstructured":"Kim K, Ginsberg HN, Choi SH. New, novel Lipid-Lowering agents for reducing cardiovascular risk: beyond Statins. Diabetes Metab J. 2022;46(4):517\u201332.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"1051_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcq165","volume":"104","author":"EJ Mills","year":"2011","unstructured":"Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of Statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials. QJM: Int J Med. 2011;104(2):109\u201324.","journal-title":"QJM: Int J Med"},{"key":"1051_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of Statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230\u20138.","journal-title":"Pharmacol Res"},{"key":"1051_CR12","doi-asserted-by":"crossref","unstructured":"Mansouri A, Reiner \u017d, Ruscica M, Tedeschi-Reiner E, Radbakhsh S, Ekta MB et al. Antioxidant effects of Statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases. J Clin Med. 2022;11(5):1313.","DOI":"10.3390\/jcm11051313"},{"issue":"4","key":"1051_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Mouhebati M, Nemati M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333\u201340.","journal-title":"Lipids"},{"key":"1051_CR14","doi-asserted-by":"crossref","unstructured":"Sahebkar A, Foroutan Z, Katsiki N, Jamialahmadi T, Mantzoros CS. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for Statin therapy? Metabolism. Clin Experimental. 2023;146:155659.","DOI":"10.1016\/j.metabol.2023.155659"},{"issue":"3","key":"1051_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1160\/th15-08-0620","volume":"115","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, \u015eerban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of Statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520\u201332.","journal-title":"Thromb Haemost"},{"key":"1051_CR16","doi-asserted-by":"crossref","unstructured":"\u015eerban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH et al. A systematic review and meta-analysis of the effect of Statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5:9902.","DOI":"10.1038\/srep09902"},{"key":"1051_CR17","doi-asserted-by":"crossref","unstructured":"Strandberg TE. Benefits and limitations of Statin use in primary cardiovascular prevention: recent advances. Pol Arch Intern Med. 2022;132(5):16258.","DOI":"10.20452\/pamw.16258"},{"issue":"1","key":"1051_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89(1):147\u201391.","journal-title":"Physiol Rev"},{"issue":"4","key":"1051_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/FJC.0000000000001320","volume":"80","author":"S Qi","year":"2022","unstructured":"Qi S, Luo X, Liu S, Ling B, Jin H. The critical effect of bile acids in atherosclerosis. J Cardiovasc Pharmacol. 2022;80(4):562\u201373.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"1051_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Therapy. 2024;9(1):97.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"1051_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1194\/jlr.M087239","volume":"59","author":"S Miyazaki-Anzai","year":"2018","unstructured":"Miyazaki-Anzai S, Masuda M, Kohno S, Levi M, Shiozaki Y, Keenan AL, et al. Simultaneous Inhibition of FXR and TGR5 exacerbates atherosclerotic formation. J Lipid Res. 2018;59(9):1709\u201313.","journal-title":"J Lipid Res"},{"key":"1051_CR22","doi-asserted-by":"crossref","unstructured":"Shanmugham M, Bellanger S, Leo CH, Gut-Derived, Metabolite. Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic diseases: Detection, Mechanism, and potential therapeutics. Pharmaceuticals (Basel). 2023;16(4):504.","DOI":"10.3390\/ph16040504"},{"issue":"7","key":"1051_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120(7):1183\u201396.","journal-title":"Circ Res"},{"key":"1051_CR24","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.phanu.2025.100435","volume":"31","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Foroushan SK, Kesharwani P, Sahebkar A. The frontier of health: exploring therapeutic potentials of the Microbiome. PharmaNutrition. 2025;31:100435.","journal-title":"PharmaNutrition"},{"issue":"11","key":"1051_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","volume":"21","author":"S Fiorucci","year":"2015","unstructured":"Fiorucci S, Distrutti E. Bile Acid-Activated Receptors, intestinal Microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21(11):702\u201314.","journal-title":"Trends Mol Med"},{"key":"1051_CR26","doi-asserted-by":"crossref","unstructured":"Russell DW. The Enzymes, Regulation, and Genetics of Bile Acid Synthesis. Annual Review of Biochemistry. 2003;72(Volume 72, 2003):137\u2009\u2013\u200974.","DOI":"10.1146\/annurev.biochem.72.121801.161712"},{"key":"1051_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","volume":"74","author":"T Li","year":"2015","unstructured":"Li T, Apte U. Bile acid metabolism and signaling in Cholestasis, Inflammation, and cancer. Adv Pharmacol. 2015;74:263\u2013302.","journal-title":"Adv Pharmacol"},{"issue":"30","key":"1051_CR28","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1074\/jbc.271.30.18017","volume":"271","author":"S Ishibashi","year":"1996","unstructured":"Ishibashi S, Schwarz M, Frykman PK, Herz J, Russell DW. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem. 1996;271(30):18017\u201323.","journal-title":"J Biol Chem"},{"issue":"2","key":"1051_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0014-5793(88)80944-X","volume":"239","author":"M Axelson","year":"1988","unstructured":"Axelson M, Aly A, Sj\u00f6vall J. Levels of 7\u03b1-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett. 1988;239(2):324\u20138.","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"1051_CR30","first-page":"s3","volume":"16","author":"O Ram\u00edrez-P\u00e9rez","year":"2017","unstructured":"Ram\u00edrez-P\u00e9rez O, Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, M\u00e9ndez-S\u00e1nchez N. The role of the gut microbiota in bile acid metabolism. Ann Hepatol. 2017;16(Suppl 1):s3\u2013105.","journal-title":"Ann Hepatol"},{"issue":"8","key":"1051_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrendo.2014.60","volume":"10","author":"F Kuipers","year":"2014","unstructured":"Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap\u2014bile acids in metabolic control. Nat Reviews Endocrinol. 2014;10(8):488\u201398.","journal-title":"Nat Reviews Endocrinol"},{"issue":"22","key":"1051_CR32","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","volume":"159","author":"AF Hofmann","year":"1999","unstructured":"Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159(22):2647\u201358.","journal-title":"Arch Intern Med"},{"issue":"7","key":"1051_CR33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.2741\/3399","volume":"14","author":"AF Hofmann","year":"2009","unstructured":"Hofmann AF. The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci (Landmark Ed). 2009;14(7):2584\u201398.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"1051_CR34","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/ijms20051214","volume":"20","author":"H Zeng","year":"2019","unstructured":"Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: A focus on colonic Microbiome, cell Proliferation, Inflammation, and cancer. Int J Mol Sci. 2019;20(5):1214.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1051_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","volume":"101","author":"C Staley","year":"2017","unstructured":"Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease States. Appl Microbiol Biotechnol. 2017;101(1):47\u201364.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1051_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall HU, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350.","journal-title":"Cell Metab"},{"issue":"2","key":"1051_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241\u201359.","journal-title":"J Lipid Res"},{"key":"1051_CR38","doi-asserted-by":"publisher","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","volume":"548","author":"JYL Chiang","year":"2022","unstructured":"Chiang JYL, Ferrell JM. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol Cell Endocrinol. 2022;548:111618.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1051_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/aps.2014.116","volume":"36","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Lu Y, Li XY. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol Sin. 2015;36(1):44\u201350.","journal-title":"Acta Pharmacol Sin"},{"key":"1051_CR40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fmed.2020.00544","volume":"7","author":"M Stofan","year":"2020","unstructured":"Stofan M, Guo GL. Bile acids and FXR: novel targets for liver diseases. Front Med (Lausanne). 2020;7:544.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"1051_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol Cell. 1999;3(5):543\u201353.","journal-title":"Mol Cell"},{"issue":"6","key":"1051_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83(6):841\u201350.","journal-title":"Cell"},{"key":"1051_CR43","doi-asserted-by":"publisher","first-page":"111617","DOI":"10.1016\/j.mce.2022.111617","volume":"548","author":"G Guthrie","year":"2022","unstructured":"Guthrie G, Vonderohe C, Burrin D. Fibroblast growth factor 15\/19 expression, regulation, and function: an overview. Mol Cell Endocrinol. 2022;548:111617.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1051_CR44","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.biotechadv.2018.03.003","volume":"36","author":"V Hiebl","year":"2018","unstructured":"Hiebl V, Ladurner A, Latkolik S, Dirsch VM. Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR. Biotechnol Adv. 2018;36(6):1657\u201398.","journal-title":"Biotechnol Adv"},{"issue":"11","key":"1051_CR45","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3390\/ijms23116046","volume":"23","author":"T Katafuchi","year":"2022","unstructured":"Katafuchi T, Makishima M. Molecular basis of bile Acid-FXR-FGF15\/19 signaling axis. Int J Mol Sci. 2022;23(11):6046.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1051_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hep.28707","volume":"65","author":"AC Donepudi","year":"2017","unstructured":"Donepudi AC, Boehme S, Li F, Chiang JY. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology. 2017;65(3):813\u201327.","journal-title":"Hepatology"},{"issue":"4, Part B","key":"1051_CR47","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","volume":"1864","author":"K Deutschmann","year":"2018","unstructured":"Deutschmann K, Reich M, Klindt C, Dr\u00f6ge C, Spomer L, H\u00e4ussinger D, et al. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2018;1864(4, Part B):1319\u201325.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"2","key":"1051_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in Gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1051_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, et al. Bile acids control inflammation and metabolic disorder through Inhibition of NLRP3 inflammasome. Immunity. 2016;45(4):802\u201316.","journal-title":"Immunity"},{"key":"1051_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fphys.2016.00646","volume":"7","author":"C Guo","year":"2016","unstructured":"Guo C, Chen WD, Wang YD. TGR5, not only a metabolic regulator. Front Physiol. 2016;7:646.","journal-title":"Front Physiol"},{"issue":"6","key":"1051_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","volume":"14","author":"TW Pols","year":"2011","unstructured":"Pols TW, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 2011;14(6):747\u201357.","journal-title":"Cell Metab"},{"key":"1051_CR52","doi-asserted-by":"crossref","unstructured":"Hylemon PB. Chapter 12 metabolism of bile acids in intestinal microflora. In: Danielsson H, Sj\u00f6vall J, editors. New comprehensive biochemistry. Volume 12. Elsevier; 1985. pp. 331\u201343.","DOI":"10.1016\/S0167-7306(08)60688-2"},{"issue":"36","key":"1051_CR53","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","volume":"105","author":"BV Jones","year":"2008","unstructured":"Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut Microbiome. Proc Natl Acad Sci U S A. 2008;105(36):13580\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1051_CR54","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1128\/AEM.72.3.1729-1738.2006","volume":"72","author":"M Begley","year":"2006","unstructured":"Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006;72(3):1729\u201338.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"1051_CR55","first-page":"e00455","volume":"7","author":"H Kim Kyung","year":"2022","unstructured":"Kim Kyung H, Park D, Jia B, Baek Ju H, Hahn Y, Jeon Che O. Identification and characterization of major bile acid 7\u03b1-Dehydroxylating bacteria in the human gut. mSystems. 2022;7(4):e00455\u201322.","journal-title":"mSystems"},{"issue":"1","key":"1051_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22\u201339.","journal-title":"Gut Microbes"},{"issue":"3","key":"1051_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1128\/aem.41.3.737-745.1981","volume":"41","author":"S Hirano","year":"1981","unstructured":"Hirano S, Nakama R, Tamaki M, Masuda N, Oda H. Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids. Appl Environ Microbiol. 1981;41(3):737\u201345.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"1051_CR58","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/aem.63.3.1185-1188.1997","volume":"63","author":"KC Doerner","year":"1997","unstructured":"Doerner KC, Takamine F, LaVoie CP, Mallonee DH, Hylemon PB. Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes. Appl Environ Microbiol. 1997;63(3):1185\u20138.","journal-title":"Appl Environ Microbiol"},{"key":"1051_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"J Ridlon","year":"2006","unstructured":"Ridlon J, Kang D-J, Hylemon P. Bile salt biotransformation by human intestinal bacteria. J Lipid Res. 2006;47:241\u201359.","journal-title":"J Lipid Res"},{"issue":"5","key":"1051_CR60","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/biom12050687","volume":"12","author":"CJ Garcia","year":"2022","unstructured":"Garcia CJ, Kosek V, Beltr\u00e1n D, Tom\u00e1s-Barber\u00e1n FA, Hajslova J. Production of new microbially conjugated bile acids by human gut microbiota. Biomolecules. 2022;12(5):687.","journal-title":"Biomolecules"},{"issue":"2","key":"1051_CR61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1194\/jlr.R088989","volume":"60","author":"A Kriaa","year":"2019","unstructured":"Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, G\u00e9rard P, et al. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 2019;60(2):323\u201332.","journal-title":"J Lipid Res"},{"issue":"7","key":"1051_CR62","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0022-2275(20)40663-7","volume":"22","author":"S Hirano","year":"1981","unstructured":"Hirano S, Masuda N. Epimerization of the 7-hydroxy group of bile acids by the combination of two kinds of microorganisms with 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activity, respectively. J Lipid Res. 1981;22(7):1060\u20138.","journal-title":"J Lipid Res"},{"issue":"1","key":"1051_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1574-6968.2004.tb09568.x","volume":"235","author":"P Lepercq","year":"2004","unstructured":"Lepercq P, G\u00e9rard P, B\u00e9guet F, Raibaud P, Grill J-P, Relano P, et al. Epimerization of Chenodeoxycholic acid to ursodeoxycholic acid by clostridium baratii isolated from human feces. FEMS Microbiol Lett. 2004;235(1):65\u201372.","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"1051_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","volume":"9","author":"DV Guzior","year":"2021","unstructured":"Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome. 2021;9(1):140.","journal-title":"Microbiome"},{"key":"1051_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1477-7819-12-164","volume":"12","author":"H Ajouz","year":"2014","unstructured":"Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol. 2014;12:164.","journal-title":"World J Surg Oncol"},{"issue":"9","key":"1051_CR66","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, et al. Increased Secondary\/Primary bile acid ratio in chronic heart failure. J Card Fail. 2017;23(9):666\u201371.","journal-title":"J Card Fail"},{"issue":"10","key":"1051_CR67","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221\u20137.","journal-title":"Gut"},{"key":"1051_CR68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/00365529609094568","volume":"216","author":"PB Mortensen","year":"1996","unstructured":"Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to Gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132\u201348.","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"1","key":"1051_CR69","first-page":"15","volume":"5","author":"DL Topping","year":"1996","unstructured":"Topping DL. Short-chain fatty acids produced by intestinal bacteria. Asia Pac J Clin Nutr. 1996;5(1):15\u20139.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"1051_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1079\/PNS2002207","volume":"62","author":"S Macfarlane","year":"2003","unstructured":"Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62(1):67\u201372.","journal-title":"Proc Nutr Soc"},{"issue":"6","key":"1051_CR71","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: Short-Chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332\u201345.","journal-title":"Cell"},{"issue":"6","key":"1051_CR72","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, B\u00e4ckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23(6):705\u201315.","journal-title":"Cell Host Microbe"},{"key":"1051_CR73","doi-asserted-by":"crossref","unstructured":"Yukino-Iwashita M, Nagatomo Y, Kawai A, Taruoka A, Yumita Y, Kagami K et al. Short-Chain fatty acids in Gut-Heart axis: their role in the pathology of heart failure. J Pers Med. 2022;12(11):1805.","DOI":"10.3390\/jpm12111805"},{"key":"1051_CR74","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","volume":"81","author":"T Hu","year":"2022","unstructured":"Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022;81:101706.","journal-title":"Ageing Res Rev"},{"key":"1051_CR75","doi-asserted-by":"publisher","first-page":"110503","DOI":"10.1016\/j.biopha.2020.110503","volume":"130","author":"F Yang","year":"2020","unstructured":"Yang F, Chen H, Gao Y, An N, Li X, Pan X, et al. Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment. Biomed Pharmacother. 2020;130:110503.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1051_CR76","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2014.07.003","volume":"20","author":"ED Sonnenburg","year":"2014","unstructured":"Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779\u201386.","journal-title":"Cell Metab"},{"issue":"4","key":"1051_CR77","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0115426506021004351","volume":"21","author":"CC Roy","year":"2006","unstructured":"Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time? Nutr Clin Pract. 2006;21(4):351\u201366.","journal-title":"Nutr Clin Pract"},{"issue":"14","key":"1051_CR78","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gad.284091.116","volume":"30","author":"M Levy","year":"2016","unstructured":"Levy M, Thaiss CA, Elinav E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. 2016;30(14):1589\u201397.","journal-title":"Genes Dev"},{"issue":"5","key":"1051_CR79","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jn\/129.5.942","volume":"129","author":"H Hara","year":"1999","unstructured":"Hara H, Haga S, Aoyama Y, Kiriyama S. Short-Chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999;129(5):942\u20138.","journal-title":"J Nutr"},{"key":"1051_CR80","doi-asserted-by":"crossref","unstructured":"Bridgeman S, Woo HC, Newsholme P, Mamotte C. Butyrate lowers cellular cholesterol through HDAC Inhibition and impaired SREBP-2 signalling. Int J Mol Sci. 2022;23(24):15506.","DOI":"10.3390\/ijms232415506"},{"issue":"50","key":"1051_CR81","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1021\/acs.jafc.7b04666","volume":"65","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Liu J, Hao W, Zhu H, Liang N, He Z, et al. Structure-Specific effects of Short-Chain fatty acids on plasma cholesterol concentration in male Syrian hamsters. J Agric Food Chem. 2017;65(50):10984\u201392.","journal-title":"J Agric Food Chem"},{"key":"1051_CR82","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jnutbio.2018.02.011","volume":"56","author":"Y Chen","year":"2018","unstructured":"Chen Y, Xu C, Huang R, Song J, Li D, Xia M. Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in Apolipoprotein E-deficient mice. J Nutr Biochem. 2018;56:175\u201382.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1051_CR83","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/MNM-210568","volume":"14","author":"MC Villalobos","year":"2021","unstructured":"Villalobos MC, Nicolas MG, Trinidad TP. Antihyperglycemic and cholesterol-lowering potential of dietary fibre from Lemongrass (Cymbopogon citratus Stapf). Mediterranean J Nutr Metabolism. 2021;14(4):453\u201367.","journal-title":"Mediterranean J Nutr Metabolism"},{"issue":"2","key":"1051_CR84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1079\/BJN19950124","volume":"74","author":"C Demign\u00e9","year":"1995","unstructured":"Demign\u00e9 C, Morand C, Levrat MA, Besson C, Moundras C, R\u00e9m\u00e9sy C. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr. 1995;74(2):209\u201319.","journal-title":"Br J Nutr"},{"issue":"6","key":"1051_CR85","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","volume":"43","author":"A Haghikia","year":"2022","unstructured":"Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur Heart J. 2022;43(6):518\u201333.","journal-title":"Eur Heart J"},{"issue":"11","key":"1051_CR86","first-page":"814","volume":"38","author":"XS Li","year":"2017","unstructured":"Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, R\u00e4ber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017;38(11):814\u201324.","journal-title":"Eur Heart J"},{"key":"1051_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.trsl.2020.08.007","volume":"228","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang Y, Ke B, Du J. TMAO: how gut microbiota contributes to heart failure. Translational Res. 2021;228:109\u201325.","journal-title":"Translational Res"},{"issue":"35","key":"1051_CR88","doi-asserted-by":"publisher","first-page":"21732","DOI":"10.1074\/jbc.M115.670471","volume":"290","author":"G Kalnins","year":"2015","unstructured":"Kalnins G, Kuka J, Grinberga S, Makrecka-Kuka M, Liepinsh E, Dambrova M, et al. Structure and function of CutC choline lyase from human microbiota bacterium Klebsiella pneumoniae. J Biol Chem. 2015;290(35):21732\u201340.","journal-title":"J Biol Chem"},{"issue":"2","key":"1051_CR89","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","volume":"6","author":"KA Romano","year":"2015","unstructured":"Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6(2):e02481.","journal-title":"mBio"},{"issue":"7122","key":"1051_CR90","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022\u20133.","journal-title":"Nature"},{"issue":"2","key":"1051_CR91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tem.2016.10.005","volume":"28","author":"CE Cho","year":"2017","unstructured":"Cho CE, Caudill MA. Trimethylamine-N-Oxide: Friend, Foe, or simply caught in the Cross-Fire? Trends Endocrinol Metab. 2017;28(2):121\u201330.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1051_CR92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17(1):49\u201360.","journal-title":"Cell Metab"},{"key":"1051_CR93","doi-asserted-by":"crossref","unstructured":"Velasquez MT, Ramezani A, Manal A, Raj DS. Trimethylamine N-Oxide: the Good, the bad and the unknown. Toxins (Basel). 2016;8(11):326.","DOI":"10.3390\/toxins8110326"},{"key":"1051_CR94","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2021.01.020","volume":"236","author":"WHW Tang","year":"2021","unstructured":"Tang WHW, Li XS, Wu Y, Wang Z, Khaw KT, Wareham NJ, et al. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study. Am Heart J. 2021;236:80\u20136.","journal-title":"Am Heart J"},{"issue":"5","key":"1051_CR95","doi-asserted-by":"publisher","first-page":"BSR20232090","DOI":"10.1042\/BSR20232090","volume":"44","author":"N Spasova","year":"2024","unstructured":"Spasova N, Somleva D, Krastev B, Ilieva R, Borizanova A, Svinarov D, et al. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases. Biosci Rep. 2024;44(5):BSR20232090.","journal-title":"Biosci Rep"},{"issue":"3","key":"1051_CR96","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/2211-5463.13762","volume":"14","author":"C-Y Hou","year":"2024","unstructured":"Hou C-Y, Chen Y-W, Hazeena SH, Tain Y-L, Hsieh C-W, Chen D-Q, et al. Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of Resveratrol and its derivatives. FEBS Open Bio. 2024;14(3):358\u201379.","journal-title":"FEBS Open Bio"},{"issue":"1","key":"1051_CR97","doi-asserted-by":"publisher","first-page":"e007281","DOI":"10.1161\/CIRCINTERVENTIONS.118.007281","volume":"12","author":"Y Tan","year":"2019","unstructured":"Tan Y, Sheng Z, Zhou P, Liu C, Zhao H, Song L, et al. Plasma trimethylamine N-Oxide as a novel biomarker for plaque rupture in patients with ST-Segment-Elevation myocardial infarction. Circ Cardiovasc Interv. 2019;12(1):e007281.","journal-title":"Circ Cardiovasc Interv"},{"key":"1051_CR98","doi-asserted-by":"crossref","unstructured":"Sun Y, Lin X, Liu Z, Hu L, Sun P, Shen G et al. Association between plasma trimethylamine N-oxide and coronary heart disease: new insights on sex and age differences. Front Cardiovasc Med. 2024;11:1397023.","DOI":"10.3389\/fcvm.2024.1397023"},{"issue":"17","key":"1051_CR99","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"1051_CR100","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12944-018-0939-6","volume":"17","author":"L Ding","year":"2018","unstructured":"Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, et al. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018;17(1):286.","journal-title":"Lipids Health Dis"},{"key":"1051_CR101","doi-asserted-by":"crossref","unstructured":"Zurkinden L, Sviridov D, Vogt B, Escher G. Downregulation of Cyp7a1 by Cholic Acid and Chenodeoxycholic Acid in Cyp27a1\/ApoE Double Knockout Mice: Differential Cardiovascular Outcome. Frontiers in Endocrinology. 2020;11.","DOI":"10.3389\/fendo.2020.586980"},{"issue":"3","key":"1051_CR102","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro.2017.149","volume":"16","author":"JM Brown","year":"2018","unstructured":"Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nat Rev Microbiol. 2018;16(3):171\u201381.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1051_CR103","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385.","journal-title":"Nat Med"},{"issue":"1","key":"1051_CR104","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10753-015-0261-7","volume":"39","author":"A Mohammadi","year":"2016","unstructured":"Mohammadi A, Najar AG, Yaghoobi MM, Jahani Y, Vahabzadeh Z. Trimethylamine-N-Oxide treatment induces changes in the ATP-Binding cassette transporter A1 and scavenger receptor A1 in murine macrophage J774A.1 cells. Inflammation. 2016;39(1):393\u2013404.","journal-title":"Inflammation"},{"issue":"7341","key":"1051_CR105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"issue":"1","key":"1051_CR106","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, et al. The gut microbial metabolite trimethylamine N-Oxide and hypertension risk: A systematic review and Dose-Response Meta-analysis. Adv Nutr. 2020;11(1):66\u201376.","journal-title":"Adv Nutr"},{"key":"1051_CR107","doi-asserted-by":"crossref","unstructured":"D\u00edez-Ricote L, Ruiz-Valderrey P, Mic\u00f3 V, Blanco-Rojo R, Tom\u00e9-Carneiro J, D\u00e1valos A et al. Trimethylamine n-Oxide (TMAO) modulates the expression of cardiovascular Disease-Related MicroRNAs and their targets. Int J Mol Sci. 2021;22(20):11145.","DOI":"10.3390\/ijms222011145"},{"key":"1051_CR108","doi-asserted-by":"publisher","first-page":"328585","DOI":"10.1155\/2015\/328585","volume":"2015","author":"SH Nam","year":"2015","unstructured":"Nam SH, Kang SG, Lee YA, Song SW, Rho JS. Association of metabolic syndrome with the cardioankle vascular index in asymptomatic Korean population. J Diabetes Res. 2015;2015:328585.","journal-title":"J Diabetes Res"},{"issue":"11","key":"1051_CR109","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-\u03baB by Toll-like receptors. Trends Mol Med. 2007;13(11):460\u20139.","journal-title":"Trends Mol Med"},{"key":"1051_CR110","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.2147\/JIR.S518155","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang W, Yin J, Han M, He W, Zhao Y, Hu J, et al. N4BP3 activates TLR4-NF-kappaB pathway in inflammatory bowel disease by promoting K48-Linked IkappaBalpha ubiquitination. J Inflamm Res. 2025;18:7167\u201381.","journal-title":"J Inflamm Res"},{"issue":"4","key":"1051_CR111","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/acel.12322","volume":"14","author":"S Gargiulo","year":"2015","unstructured":"Gargiulo S, Gamba P, Testa G, Rossin D, Biasi F, Poli G, et al. Relation between TLR4\/NF-\u03baB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability. Aging Cell. 2015;14(4):569\u201381.","journal-title":"Aging Cell"},{"issue":"12","key":"1051_CR112","first-page":"5850","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Li H, Dong X, Wang X, Zhu J, Cheng Y, et al. Expression of NF-\u03baB and TLR-4 is associated with the occurrence, progression and prognosis of esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2018;11(12):5850\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"1051_CR113","doi-asserted-by":"crossref","unstructured":"Lei D, Yu W, Liu Y, Jiang Y, Li X, Lv J et al. Trimethylamine N-Oxide (TMAO) inducing endothelial injury: UPLC-MS\/MS-Based quantification and the activation of cathepsin B-Mediated NLRP3 inflammasome. Molecules. 2023;28(9):3817.","DOI":"10.3390\/molecules28093817"},{"issue":"1","key":"1051_CR114","doi-asserted-by":"publisher","first-page":"20303","DOI":"10.1038\/s41598-023-46820-7","volume":"13","author":"M Shanmugham","year":"2023","unstructured":"Shanmugham M, Devasia AG, Chin YL, Cheong KH, Ong ES, Bellanger S, et al. Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction. Sci Rep. 2023;13(1):20303.","journal-title":"Sci Rep"},{"issue":"6","key":"1051_CR115","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/ajcn\/nqaa015","volume":"111","author":"BC Fu","year":"2020","unstructured":"Fu BC, Hullar MAJ, Randolph TW, Franke AA, Monroe KR, Cheng I, et al. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal Microbiome in the multiethnic cohort adiposity phenotype study. Am J Clin Nutr. 2020;111(6):1226\u201334.","journal-title":"Am J Clin Nutr"},{"issue":"22","key":"1051_CR116","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.21037\/atm-21-5043","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, Shao Y, Tu J, Sun J, Li L, Tao J, et al. Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling. Ann Transl Med. 2021;9(22):1670.","journal-title":"Ann Transl Med"},{"issue":"9","key":"1051_CR117","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1021\/ar9800587","volume":"36","author":"NS Sampson","year":"2003","unstructured":"Sampson NS, Vrielink A. Cholesterol oxidases: a study of nature\u2019s approach to protein design. Acc Chem Res. 2003;36(9):713\u201322.","journal-title":"Acc Chem Res"},{"issue":"1","key":"1051_CR118","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00041433-200202000-00010","volume":"13","author":"ND Ernst","year":"2002","unstructured":"Ernst ND, Cleeman JI. National cholesterol education program keeps a priority on lifestyle modification to decrease cardiovascular disease risk. Curr Opin Lipidol. 2002;13(1):69\u201373.","journal-title":"Curr Opin Lipidol"},{"issue":"13","key":"1051_CR119","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1021\/bi00465a003","volume":"29","author":"L Gr\u00f6nberg","year":"1990","unstructured":"Gr\u00f6nberg L, Slotte JP. Cholesterol oxidase catalyzed oxidation of cholesterol in mixed lipid monolayers: effects of surface pressure and phospholipid composition on catalytic activity. Biochemistry. 1990;29(13):3173\u20138.","journal-title":"Biochemistry"},{"issue":"11","key":"1051_CR120","first-page":"1636","volume":"33","author":"K Arima","year":"1969","unstructured":"Arima K, Nagasawa M, Bae M, Tamura G. Microbial transformation of sterols: part I. Decomposition of cholesterol by microorganismspart II. Cleavage of sterol side chains by microorganisms. Agric Biol Chem. 1969;33(11):1636\u201350.","journal-title":"Agric Biol Chem"},{"issue":"1","key":"1051_CR121","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s43141-022-00433-1","volume":"20","author":"AA Alam","year":"2022","unstructured":"Alam AA, Goda DA, Soliman NA, Abdel-Meguid DI, El-Sharouny EE, Sabry SA. Production and statistical optimization of cholesterol-oxidase generated by streptomyces sp. AN strain. J Genetic Eng Biotechnol. 2022;20(1):156.","journal-title":"J Genetic Eng Biotechnol"},{"key":"1051_CR122","doi-asserted-by":"publisher","first-page":"1359528","DOI":"10.1155\/2019\/1359528","volume":"2019","author":"H Wali","year":"2019","unstructured":"Wali H, Rehman FU, Umar A, Ahmed S. Cholesterol degradation and production of extracellular cholesterol oxidase from Bacillus pumilus W1 and Serratia marcescens W8. Biomed Res Int. 2019;2019:1359528.","journal-title":"Biomed Res Int"},{"issue":"2","key":"1051_CR123","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0922-338X(95)94077-5","volume":"79","author":"D Wilma\u0144ska","year":"1995","unstructured":"Wilma\u0144ska D, Dziadek J, Sajduda A, Milczarek K, Jaworski A, Murooka Y. Identification of cholesterol oxidase from fast-growing mycobacterial strains and Rhodococcus Sp. J Ferment Bioeng. 1995;79(2):119\u201324.","journal-title":"J Ferment Bioeng"},{"issue":"3","key":"1051_CR124","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1042\/bj2010515","volume":"201","author":"PSJ Cheetham","year":"1982","unstructured":"Cheetham PSJ, Dunnill P, Lilly MD. The characterization and interconversion of three forms of cholesterol oxidase extracted from nocardia rhodochrous. Biochem J. 1982;201(3):515\u201321.","journal-title":"Biochem J"},{"issue":"1","key":"1051_CR125","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s42398-018-0008-0","volume":"1","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Singh V, Tripathi CKM. Scale up and optimization of cholesterol oxidase production from streptomyces rimosus MTCC 10792 in a 3-L bioreactor. Environ Sustain. 2018;1(1):99\u2013107.","journal-title":"Environ Sustain"},{"issue":"5\u20136","key":"1051_CR126","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s12010-011-9360-6","volume":"165","author":"V Praveen","year":"2011","unstructured":"Praveen V, Srivastava A, Tripathi CK. Purification and characterization of the enzyme cholesterol oxidase from a new isolate of streptomyces Sp. Appl Biochem Biotechnol. 2011;165(5\u20136):1414\u201326.","journal-title":"Appl Biochem Biotechnol"},{"key":"1051_CR127","doi-asserted-by":"crossref","unstructured":"Kumari L, Kanwar SS. Cholesterol oxidase and its applications. 2012.","DOI":"10.4236\/aim.2012.22007"},{"issue":"18","key":"1051_CR128","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1128\/AEM.02806-06","volume":"73","author":"P G\u00e9rard","year":"2007","unstructured":"G\u00e9rard P, Lepercq P, Leclerc M, Gavini F, Raibaud P, Juste C. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol. 2007;73(18):5742\u20139.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"1051_CR129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0039-128X(95)00173-N","volume":"61","author":"D Ren","year":"1996","unstructured":"Ren D, Li L, Schwabacher AW, Young JW, Beitz DC. Mechanism of cholesterol reduction to Coprostanol by Eubacterium Coprostanoligenes ATCC 51222. Steroids. 1996;61(1):33\u201340.","journal-title":"Steroids"},{"issue":"1","key":"1051_CR130","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s10020-020-00234-7","volume":"26","author":"M Li","year":"2020","unstructured":"Li M, Chen WD, Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol Med. 2020;26(1):101.","journal-title":"Mol Med"},{"issue":"5","key":"1051_CR131","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1038\/emm.2017.20","volume":"49","author":"R Okumura","year":"2017","unstructured":"Okumura R, Takeda K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp Mol Med. 2017;49(5):e338\u2013e.","journal-title":"Exp Mol Med"},{"key":"1051_CR132","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.csbj.2022.05.024","volume":"20","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang W, Wu X, Liang X, Cao L, Zhai J, et al. MIAOME: human Microbiome affect the host epigenome. Comput Struct Biotechnol J. 2022;20:2455\u201363.","journal-title":"Comput Struct Biotechnol J"},{"key":"1051_CR133","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13059-015-0763-5","volume":"16","author":"DH Yu","year":"2015","unstructured":"Yu DH, Gadkari M, Zhou Q, Yu S, Gao N, Guan Y, et al. Postnatal epigenetic regulation of intestinal stem cells requires DNA methylation and is guided by the Microbiome. Genome Biol. 2015;16:211.","journal-title":"Genome Biol"},{"issue":"9","key":"1051_CR134","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang Y, TET-mediated active. DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18(9):517\u201334.","journal-title":"Nat Rev Genet"},{"key":"1051_CR135","doi-asserted-by":"publisher","first-page":"815977","DOI":"10.3389\/fphar.2022.815977","volume":"13","author":"Y Dai","year":"2022","unstructured":"Dai Y, Chen D, Xu T. DNA methylation aberrant in atherosclerosis. Front Pharmacol. 2022;13:815977.","journal-title":"Front Pharmacol"},{"key":"1051_CR136","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2020.11.013","volume":"512","author":"H Hou","year":"2021","unstructured":"Hou H, Zhao H. Epigenetic factors in atherosclerosis: DNA methylation, folic acid metabolism, and intestinal microbiota. Clin Chim Acta. 2021;512:7\u201311.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1051_CR137","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41564-019-0659-3","volume":"5","author":"I Ansari","year":"2020","unstructured":"Ansari I, Raddatz G, Gutekunst J, Ridnik M, Cohen D, Abu-Remaileh M, et al. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat Microbiol. 2020;5(4):610\u20139.","journal-title":"Nat Microbiol"},{"issue":"1","key":"1051_CR138","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/nu3010118","volume":"3","author":"M Rossi","year":"2011","unstructured":"Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients. 2011;3(1):118\u201334.","journal-title":"Nutrients"},{"key":"1051_CR139","unstructured":"Mariyappan K, Dattatraya N. A Review On Production Of Folate From Probiotic Bacteria. 2022."},{"issue":"12","key":"1051_CR140","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1093\/jn\/137.12.2742","volume":"137","author":"A Pompei","year":"2007","unstructured":"Pompei A, Cordisco L, Amaretti A, Zanoni S, Raimondi S, Matteuzzi D, et al. Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J Nutr. 2007;137(12):2742\u20136.","journal-title":"J Nutr"},{"key":"1051_CR141","doi-asserted-by":"publisher","first-page":"109339","DOI":"10.1016\/j.lwt.2020.109339","volume":"127","author":"AL Mosso","year":"2020","unstructured":"Mosso AL, LeBlanc JG, Motta C, Castanheira I, Ribotta P, Samm\u00e1n N. Effect of fermentation in nutritional, textural and sensorial parameters of vegan-spread products using a probiotic folate-producing Lactobacillus Sakei strain. LWT. 2020;127:109339.","journal-title":"LWT"},{"key":"1051_CR142","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fgene.2015.00148","volume":"6","author":"S Magn\u00fasd\u00f3ttir","year":"2015","unstructured":"Magn\u00fasd\u00f3ttir S, Ravcheev D, de Cr\u00e9cy-Lagard V, Thiele I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet. 2015;6:148.","journal-title":"Front Genet"},{"issue":"4","key":"1051_CR143","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","volume":"128","author":"BE Bernstein","year":"2007","unstructured":"Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128(4):669\u201381.","journal-title":"Cell"},{"issue":"1","key":"1051_CR144","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12964-023-01298-8","volume":"21","author":"L Zhang","year":"2023","unstructured":"Zhang L, Xia C, Yang Y, Sun F, Zhang Y, Wang H, et al. DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. Cell Communication Signal. 2023;21(1):344.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"1051_CR145","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrg.2016.138","volume":"18","author":"SH Stricker","year":"2017","unstructured":"Stricker SH, K\u00f6ferle A, Beck S. From profiles to function in epigenomics. Nat Rev Genet. 2017;18(1):51\u201366.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"1051_CR146","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","volume":"29","author":"B van der Hee","year":"2021","unstructured":"van der Hee B, Wells JM. Microbial regulation of host physiology by Short-chain fatty acids. Trends Microbiol. 2021;29(8):700\u201312.","journal-title":"Trends Microbiol"},{"issue":"5","key":"1051_CR147","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","volume":"13","author":"DR Donohoe","year":"2011","unstructured":"Donohoe DR, Garge N, Zhang X, Sun W, O\u2019Connell TM, Bunger MK, et al. The Microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517\u201326.","journal-title":"Cell Metab"},{"issue":"7","key":"1051_CR148","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2016.05.018","volume":"165","author":"GE Kaiko","year":"2016","unstructured":"Kaiko GE, Ryu SH, Koues OI, Collins PL, Solnica-Krezel L, Pearce EJ, et al. The colonic crypt protects stem cells from Microbiota-Derived metabolites. Cell. 2016;165(7):1708\u201320.","journal-title":"Cell"},{"key":"1051_CR149","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","volume":"130","author":"RA Bagchi","year":"2019","unstructured":"Bagchi RA, Weeks KL. Histone deacetylases in cardiovascular and metabolic diseases. J Mol Cell Cardiol. 2019;130:151\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"1051_CR150","doi-asserted-by":"crossref","unstructured":"Tayyeb JZ, Popeijus HE, Mensink RP, Konings M, Mokhtar FBA, Plat J. Short-Chain fatty acids (Except hexanoic Acid) lower NF-kB Transactivation, which rescues Inflammation-Induced decreased Apolipoprotein A-I transcription in HepG2 cells. Int J Mol Sci. 2020;21(14):5088 .","DOI":"10.3390\/ijms21145088"},{"key":"1051_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2015.03.004","volume":"70","author":"XH Yu","year":"2015","unstructured":"Yu XH, Zheng XL, Tang CK. Nuclear Factor-\u03baB activation as a pathological mechanism of lipid metabolism and atherosclerosis. Adv Clin Chem. 2015;70:1\u201330.","journal-title":"Adv Clin Chem"},{"issue":"5","key":"1051_CR152","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","volume":"25","author":"MPJ de Winther","year":"2005","unstructured":"de Winther MPJ, Kanters E, Kraal G, Hofker MH, Arteriosclerosis. Thromb Vascular Biology. 2005;25(5):904\u201314.","journal-title":"Thromb Vascular Biology"},{"key":"1051_CR153","doi-asserted-by":"crossref","unstructured":"Rashid S, Sado AI, Afzal MS, Ahmed A, Almaalouli B, Waheed T et al. Role of gut microbiota in cardiovascular diseases \u2013 a comprehensive review. Annals Med Surg. 2024;86(3):1483-9.","DOI":"10.1097\/MS9.0000000000001419"},{"key":"1051_CR154","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.medmic.2023.100096","volume":"19","author":"P Singh","year":"2024","unstructured":"Singh P, Meenatchi R, Ahmed ZHT, Thacharodi A, M R, Kumar RRS, et al. Implications of the gut Microbiome in cardiovascular diseases: association of gut Microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine. Med Microecology. 2024;19:100096.","journal-title":"Med Microecology"},{"issue":"1","key":"1051_CR155","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1038\/s41598-022-09510-4","volume":"12","author":"E Aune","year":"2022","unstructured":"Aune E, McMurray J, Lundgren P, Sattar N, Israelsson J, Nordberg P, et al. Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest. Sci Rep. 2022;12(1):5685.","journal-title":"Sci Rep"},{"issue":"17","key":"1051_CR156","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1051_CR157","doi-asserted-by":"crossref","unstructured":"Mu F, Tang M, Guan Y, Lin R, Zhao M, Zhao J et al. Knowledge mapping of the links between the gut microbiota and heart failure: A scientometric investigation (2006\u20132021). Front Cardiovasc Med. 2022;9:882660.","DOI":"10.3389\/fcvm.2022.882660"},{"issue":"12","key":"1051_CR158","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","volume":"21","author":"Y Nagatomo","year":"2015","unstructured":"Nagatomo Y, Tang WH. Intersections between Microbiome and heart failure: revisiting the gut hypothesis. J Card Fail. 2015;21(12):973\u201380.","journal-title":"J Card Fail"},{"issue":"1","key":"1051_CR159","first-page":"5","volume":"5","author":"D Feng","year":"2021","unstructured":"Feng D, Christensen JT, Yetman AT, Lindsey ML, Singh AB, Salomon JD. The microbiome\u2019s relationship with congenital heart disease: more than a gut feeling. J Congenital Cardiol. 2021;5(1):5.","journal-title":"J Congenital Cardiol"},{"issue":"11","key":"1051_CR160","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cardfail.2016.06.005","volume":"22","author":"P Mamic","year":"2016","unstructured":"Mamic P, Heidenreich PA, Hedlin H, Tennakoon L, Staudenmayer KL. Hospitalized patients with heart failure and common bacterial infections: A nationwide analysis of concomitant clostridium difficile infection rates and In-Hospital mortality. J Card Fail. 2016;22(11):891\u2013900.","journal-title":"J Card Fail"},{"key":"1051_CR161","doi-asserted-by":"publisher","first-page":"1147438","DOI":"10.3389\/fcvm.2023.1147438","volume":"10","author":"X Cui","year":"2023","unstructured":"Cui X, Su Y, Huang X, Chen J, Ma J, Liao P, et al. Combined analysis of plasma metabolome and intestinal Microbiome sequencing to explore Jiashen prescription and its potential role in changing intestine-heart axis and effect on chronic heart failure. Front Cardiovasc Med. 2023;10:1147438.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"1051_CR162","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, et al. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 2016;4(3):220\u20137.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"1051_CR163","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","volume":"16","author":"WHW Tang","year":"2019","unstructured":"Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol. 2019;16(3):137\u201354.","journal-title":"Nat Rev Cardiol"},{"issue":"9167","key":"1051_CR164","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","volume":"353","author":"J Niebauer","year":"1999","unstructured":"Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353(9167):1838\u201342.","journal-title":"Lancet"},{"issue":"16","key":"1051_CR165","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WHW Tang","year":"2019","unstructured":"Tang WHW, B\u00e4ckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;73(16):2089\u2013105.","journal-title":"J Am Coll Cardiol"},{"key":"1051_CR166","doi-asserted-by":"publisher","first-page":"5164298","DOI":"10.1155\/2019\/5164298","volume":"2019","author":"Q Jia","year":"2019","unstructured":"Jia Q, Li H, Zhou H, Zhang X, Zhang A, Xie Y, et al. Role and effective therapeutic target of gut microbiota in heart failure. Cardiovasc Ther. 2019;2019:5164298.","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"1051_CR167","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde M, Winkler T, Heinsen FA, R\u00fchlemann MC, Spehlmann ME, Bajrovic A, et al. Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail. 2017;4(3):282\u201390.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"1051_CR168","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"M Tr\u00f8seid","year":"2015","unstructured":"Tr\u00f8seid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med. 2015;277(6):717\u201326.","journal-title":"J Intern Med"},{"key":"1051_CR169","doi-asserted-by":"publisher","first-page":"817396","DOI":"10.3389\/fcvm.2022.817396","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, Fan Z, Cui J, Li D, Lu J, Cui X, et al. Trimethylamine N-Oxide in heart failure: A Meta-Analysis of prognostic value. Front Cardiovasc Med. 2022;9:817396.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1051_CR170","doi-asserted-by":"publisher","first-page":"e002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","volume":"9","author":"CL Organ","year":"2016","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline diet and its gut Microbe-Derived Metabolite, trimethylamine N-Oxide, exacerbate pressure Overload-Induced heart failure. Circ Heart Fail. 2016;9(1):e002314.","journal-title":"Circ Heart Fail"},{"issue":"25","key":"1051_CR171","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.jacc.2017.10.064","volume":"70","author":"K Schuett","year":"2017","unstructured":"Schuett K, Kleber ME, Scharnagl H, Lorkowski S, M\u00e4rz W, Niessner A, et al. Trimethylamine-N-oxide and heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2017;70(25):3202\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1051_CR172","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/heartjnl-2021-320054","volume":"108","author":"S Lv","year":"2022","unstructured":"Lv S, Wang Y, Zhang W, Shang H. Trimethylamine oxide: a potential target for heart failure therapy. Heart. 2022;108(12):917\u201322.","journal-title":"Heart"},{"key":"1051_CR173","doi-asserted-by":"crossref","unstructured":"Spehlmann ME, Rangrez AY, Dhotre DP, Schmiedel N, Chavan N, Bang C et al. Heart failure severity closely correlates with intestinal dysbiosis and subsequent metabolomic alterations. Biomedicines. 2022;10(4):809.","DOI":"10.3390\/biomedicines10040809"},{"key":"1051_CR174","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","volume":"52","author":"M Tr\u00f8seid","year":"2020","unstructured":"Tr\u00f8seid M, Andersen G, Broch K, Hov JR. The gut Microbiome in coronary artery disease and heart failure: current knowledge and future directions. EBioMedicine. 2020;52:102649.","journal-title":"EBioMedicine"},{"issue":"8","key":"1051_CR175","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023;132(8):1050\u201363.","journal-title":"Circ Res"},{"issue":"1","key":"1051_CR176","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14.","journal-title":"Microbiome"},{"issue":"6","key":"1051_CR177","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331\u201340.","journal-title":"Hypertension"},{"key":"1051_CR178","doi-asserted-by":"publisher","first-page":"2923941","DOI":"10.1155\/2022\/2923941","volume":"2022","author":"TK Joishy","year":"2022","unstructured":"Joishy TK, Jha A, Oudah M, Das S, Adak A, Deb D, et al. Human gut microbes associated with systolic blood pressure. Int J Hypertens. 2022;2022:2923941.","journal-title":"Int J Hypertens"},{"issue":"6","key":"1051_CR179","doi-asserted-by":"publisher","first-page":"872","DOI":"10.7150\/ijms.29322","volume":"16","author":"X Dan","year":"2019","unstructured":"Dan X, Mushi Z, Baili W, Han L, Enqi W, Huanhu Z, et al. Differential analysis of Hypertension-Associated intestinal microbiota. Int J Med Sci. 2019;16(6):872\u201381.","journal-title":"Int J Med Sci"},{"key":"1051_CR180","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Lulla A, Cheng X, Yeo J-Y, Mandal J, Yang T et al. Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites. J Hypertens. 2023;41(6):979-94.","DOI":"10.1097\/HJH.0000000000003423"},{"issue":"2","key":"1051_CR181","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.RES.0000200400.55539.85","volume":"98","author":"F He","year":"2006","unstructured":"He F, Li J, Mu Y, Kuruba R, Ma Z, Wilson A, et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res. 2006;98(2):192\u20139.","journal-title":"Circ Res"},{"key":"1051_CR182","doi-asserted-by":"crossref","unstructured":"Klindt C, Reich M, Hellwig B, Stindt J, Rahnenf\u00fchrer J, Hengstler JG et al. The G Protein-Coupled bile acid receptor TGR5 (Gpbar1) modulates Endothelin-1 signaling in liver. Cells. 2019;8(11):1467.","DOI":"10.3390\/cells8111467"},{"key":"1051_CR183","doi-asserted-by":"publisher","first-page":"117147","DOI":"10.1016\/j.atherosclerosis.2023.05.016","volume":"384","author":"BJH Verhaar","year":"2023","unstructured":"Verhaar BJH, Mosterd CM, Collard D, Galenkamp H, Muller M, Rampanelli E, et al. Sex differences in associations of plasma metabolites with blood pressure and heart rate variability: the HELIUS study. Atherosclerosis. 2023;384:117147.","journal-title":"Atherosclerosis"},{"issue":"6","key":"1051_CR184","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1073\/pnas.1323977111","volume":"111","author":"X Zhang","year":"2014","unstructured":"Zhang X, Huang S, Gao M, Liu J, Jia X, Han Q, et al. Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice. Proc Natl Acad Sci U S A. 2014;111(6):2277\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1051_CR185","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1681\/ASN.2018030271","volume":"29","author":"S Li","year":"2018","unstructured":"Li S, Qiu M, Kong Y, Zhao X, Choi HJ, Reich M, et al. Bile acid G Protein-Coupled membrane receptor TGR5 modulates Aquaporin 2-Mediated water homeostasis. J Am Soc Nephrol. 2018;29(11):2658\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"1051_CR186","doi-asserted-by":"publisher","unstructured":"Zhang B, Ayyaswamy S, Bryan R, Durgan D. Reduced bile acid signaling contributes to hypertension development in spontaneously hypertensive Stroke-Prone r ats. FASEB J. 2021;35(S1). https:\/\/doi.org\/10.1096\/fasebj.2021.35.S1.03907","DOI":"10.1096\/fasebj.2021.35.S1.03907"},{"issue":"3","key":"1051_CR187","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.bbrc.2012.09.104","volume":"427","author":"DP Kumar","year":"2012","unstructured":"Kumar DP, Rajagopal S, Mahavadi S, Mirshahi F, Grider JR, Murthy KS, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic \u03b2 cells. Biochem Biophys Res Commun. 2012;427(3):600\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1051_CR188","doi-asserted-by":"publisher","first-page":"e2778","DOI":"10.1097\/MD.0000000000002778","volume":"95","author":"W Sun","year":"2016","unstructured":"Sun W, Zhang D, Wang Z, Sun J, Xu B, Chen Y, et al. Insulin resistance is associated with total bile acid level in type 2 diabetic and nondiabetic population: A Cross-Sectional study. Med (Baltim). 2016;95(10):e2778.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1051_CR189","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/s41598-020-63475-w","volume":"10","author":"L Calder\u00f3n-P\u00e9rez","year":"2020","unstructured":"Calder\u00f3n-P\u00e9rez L, Gosalbes MJ, Yuste S, Valls RM, Pedret A, Llaurad\u00f3 E, et al. Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study. Sci Rep. 2020;10(1):6436.","journal-title":"Sci Rep"},{"key":"1051_CR190","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.phrs.2019.01.019","volume":"141","author":"RJF Felizardo","year":"2019","unstructured":"Felizardo RJF, Watanabe IKM, Dardi P, Rossoni LV, C\u00e2mara NOS. The interplay among gut microbiota, hypertension and kidney diseases: the role of short-chain fatty acids. Pharmacol Res. 2019;141:366\u201377.","journal-title":"Pharmacol Res"},{"issue":"6","key":"1051_CR191","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1152\/jn.00067.2021","volume":"125","author":"YJ Peng","year":"2021","unstructured":"Peng YJ, Su X, Wang B, Matthews T, Nanduri J, Prabhakar NR. Role of olfactory receptor78 in carotid body-dependent sympathetic activation and hypertension in murine models of chronic intermittent hypoxia. J Neurophysiol. 2021;125(6):2054\u201367.","journal-title":"J Neurophysiol"},{"issue":"11","key":"1051_CR192","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","volume":"48","author":"N Natarajan","year":"2016","unstructured":"Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics. 2016;48(11):826\u201334.","journal-title":"Physiol Genomics"},{"key":"1051_CR193","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.redox.2021.102115","volume":"46","author":"S Jiang","year":"2021","unstructured":"Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II\u2013induced hypertension. Redox Biol. 2021;46:102115.","journal-title":"Redox Biol"},{"issue":"1","key":"1051_CR194","first-page":"9512401","volume":"2022","author":"G-d He","year":"2022","unstructured":"He G-d, Liu X-c, Lu A-s, Feng Y-q. Association of choline intake with blood pressure and effects of its Microbiota-Dependent metabolite Trimethylamine-N-Oxide on hypertension. Cardiovasc Ther. 2022;2022(1):9512401.","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"1051_CR195","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/HYPERTENSIONAHA.120.16895","volume":"78","author":"VE Brunt","year":"2021","unstructured":"Brunt VE, Casso AG, Gioscia-Ryan RA, Sapinsley ZJ, Ziemba BP, Clayton ZS, et al. Gut Microbiome-Derived metabolite trimethylamine N-Oxide induces aortic stiffening and increases systolic blood pressure with aging in mice and humans. Hypertension. 2021;78(2):499\u2013511.","journal-title":"Hypertension"},{"key":"1051_CR196","doi-asserted-by":"crossref","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL et al. Trimethylamine N-Oxide promotes vascular inflammation through signaling of Mitogen-Activated protein kinase and nuclear Factor-\u03baB. J Am Heart Assoc. 2016;5(2):e002767.","DOI":"10.1161\/JAHA.115.002767"},{"issue":"45","key":"1051_CR197","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1093\/eurheartj\/ehad446","volume":"44","author":"ME Makover","year":"2023","unstructured":"Makover ME, Surma S, Banach M, Toth PP. Eliminating atherosclerotic cardiovascular disease residual risk. Eur Heart J. 2023;44(45):4731\u20133.","journal-title":"Eur Heart J"},{"issue":"10","key":"1051_CR198","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630\u201345.","journal-title":"Cell"},{"issue":"3","key":"1051_CR199","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/ijms26031364","volume":"26","author":"V Tasouli-Drakou","year":"2025","unstructured":"Tasouli-Drakou V, Ogurek I, Shaikh T, Ringor M, DiCaro MV, Lei K. Atherosclerosis: A comprehensive review of molecular factors and mechanisms. Int J Mol Sci. 2025;26(3):1364.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"1051_CR200","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.2174\/0929867328666211213112949","volume":"29","author":"AM Antonis","year":"2022","unstructured":"Antonis AM, Theodora AM, Helen M, Antonis SM. Gut microbiota and cardiovascular disease: symbiosis versus dysbiosis. Curr Med Chem. 2022;29(23):4050\u201377.","journal-title":"Curr Med Chem"},{"issue":"7","key":"1051_CR201","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.105.579979","volume":"113","author":"SJ Ott","year":"2006","unstructured":"Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 2006;113(7):929\u201337.","journal-title":"Circulation"},{"issue":"12","key":"1051_CR202","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/obr.12750","volume":"19","author":"ICL van den Munckhof","year":"2018","unstructured":"van den Munckhof ICL, Kurilshikov A, ter Horst R, Riksen NP, Joosten LAB, Zhernakova A, et al. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obes Rev. 2018;19(12):1719\u201334.","journal-title":"Obes Rev"},{"issue":"1Suppl 1","key":"1051_CR203","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren O, Spor A, Felin J, F\u00e5k F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(1Suppl 1):4592\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1051_CR204","doi-asserted-by":"publisher","first-page":"3796359","DOI":"10.1155\/2017\/3796359","volume":"2017","author":"L Cui","year":"2017","unstructured":"Cui L, Zhao T, Hu H, Zhang W, Hua X. Association study of gut flora in coronary heart disease through High-Throughput sequencing. Biomed Res Int. 2017;2017:3796359.","journal-title":"Biomed Res Int"},{"key":"1051_CR205","doi-asserted-by":"crossref","unstructured":"Jie Z, Zhu Q, Zou Y, Wu Q, Qin M, He D et al. A consortium of three-bacteria isolated from human feces inhibits formation of atherosclerotic deposits and lowers lipid levels in a mouse model. iScience. 2023;26(6):106960 .","DOI":"10.1016\/j.isci.2023.106960"},{"issue":"3","key":"1051_CR206","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/medicina57030195","volume":"57","author":"H Szabo","year":"2021","unstructured":"Szabo H, Hernyes A, Piroska M, Ligeti B, Fussy P, Zoldi L, et al. Association between gut microbial diversity and carotid Intima-Media thickness. Medicina. 2021;57(3):195.","journal-title":"Medicina"},{"issue":"1","key":"1051_CR207","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S, et al. The gut Microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845.","journal-title":"Nat Commun"},{"issue":"5","key":"1051_CR208","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20171107","volume":"132","author":"WL Lau","year":"2018","unstructured":"Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered Microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond). 2018;132(5):509\u201322.","journal-title":"Clin Sci (Lond)"},{"key":"1051_CR209","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm13195794","volume":"13","author":"Y Laryushina","year":"2024","unstructured":"Laryushina Y, Samoilova-Bedych N, Turgunova L, Kozhakhmetov S, Alina A, Suieubayev M, et al. Alterations of the gut Microbiome and TMAO levels in patients with ulcerative colitis. J Clin Med. 2024;13:19.","journal-title":"J Clin Med"},{"issue":"17","key":"1051_CR210","doi-asserted-by":"publisher","first-page":"e020646","DOI":"10.1161\/JAHA.120.020646","volume":"10","author":"Y Lee","year":"2021","unstructured":"Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, et al. Longitudinal plasma measures of trimethylamine N-Oxide and risk of atherosclerotic cardiovascular disease events in Community\u2010Based older adults. J Am Heart Association. 2021;10(17):e020646.","journal-title":"J Am Heart Association"},{"issue":"8","key":"1051_CR211","first-page":"1252","volume":"36","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhou J, Liu C, Zhou P, Sheng Z, Li J, et al. Association between plasma trimethylamine N-oxide and neoatherosclerosis in patients with very late stent thrombosis. Can J Cardiol. 2020;36(8):1252\u201360.","journal-title":"Can J Cardiol"},{"issue":"6","key":"1051_CR212","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","volume":"24","author":"EC Aguilar","year":"2014","unstructured":"Aguilar EC, Leonel AJ, Teixeira LG, Silva AR, Silva JF, Pelaez JM, et al. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation. Nutr Metab Cardiovasc Dis. 2014;24(6):606\u201313.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"1051_CR213","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5551\/jat.RV17006","volume":"24","author":"H Ohira","year":"2017","unstructured":"Ohira H, Tsutsui W, Fujioka Y. Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb. 2017;24(7):660\u201372.","journal-title":"J Atheroscler Thromb"},{"key":"1051_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2018.12.006","volume":"483","author":"A Schmid","year":"2019","unstructured":"Schmid A, Schlegel J, Thomalla M, Karrasch T, Sch\u00e4ffler A. Evidence of functional bile acid signaling pathways in adipocytes. Mol Cell Endocrinol. 2019;483:1\u201310.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1051_CR215","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2016.03.008","volume":"584","author":"S Ghosh","year":"2016","unstructured":"Ghosh S, Dass JFP. Study of pathway cross-talk interactions with NF-\u03baB leading to its activation via ubiquitination or phosphorylation: A brief review. Gene. 2016;584(1):97\u2013109.","journal-title":"Gene"},{"issue":"7","key":"1051_CR216","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","volume":"33","author":"T Kida","year":"2013","unstructured":"Kida T, Tsubosaka Y, Hori M, Ozaki H, Murata T. Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(7):1663\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1051_CR217","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1194\/jlr.M500390-JLR200","volume":"46","author":"EA Hanniman","year":"2005","unstructured":"Hanniman EA, Lambert G, McCarthy TC, Sinal CJ. Loss of functional farnesoid X receptor increases atherosclerotic lesions in Apolipoprotein E-deficient mice. J Lipid Res. 2005;46(12):2595\u2013604.","journal-title":"J Lipid Res"},{"issue":"3","key":"1051_CR218","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tcm.2018.08.003","volume":"29","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Sannino A, Esposito G, Perrino C. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases. Trends Cardiovasc Med. 2019;29(3):141\u20137.","journal-title":"Trends Cardiovasc Med"},{"issue":"6052","key":"1051_CR219","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, et al. Linking Long-Term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105\u20138.","journal-title":"Science"},{"issue":"3","key":"1051_CR220","doi-asserted-by":"publisher","first-page":"e3004","DOI":"10.1002\/jmr.3004","volume":"36","author":"E Palab\u0131y\u0131k","year":"2023","unstructured":"Palab\u0131y\u0131k E, Sulumer AN, Uguz H, Avc\u0131 B, Ask\u0131n S, Ask\u0131n H, et al. Assessment of hypolipidemic and anti-inflammatory properties of walnut (Juglans regia) seed coat extract and modulates some metabolic enzymes activity in triton WR-1339-induced hyperlipidemia in rat kidney, liver, and heart. J Mol Recognit. 2023;36(3):e3004.","journal-title":"J Mol Recognit"},{"issue":"1","key":"1051_CR221","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12937-024-01060-x","volume":"24","author":"J Yu","year":"2025","unstructured":"Yu J, Wu Y, Zhu Z, Lu H. The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic review. Nutr J. 2025;24(1):17.","journal-title":"Nutr J"},{"issue":"10338","key":"1051_CR222","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","volume":"399","author":"J Delgado-Lista","year":"2022","unstructured":"Delgado-Lista J, Alcala-Diaz JF, Torres-Pe\u00f1a JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, et al. Long-term secondary prevention of cardiovascular disease with a mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet. 2022;399(10338):1876\u201385.","journal-title":"Lancet"},{"key":"1051_CR223","doi-asserted-by":"crossref","unstructured":"Urpi-Sarda M, Casas R, Sacanella E, Corella D, Andr\u00e9s-Lacueva C, Llorach R et al. The 3-Year effect of the mediterranean diet intervention on inflammatory biomarkers related to cardiovascular disease. Biomedicines. 2021;9(8):862.","DOI":"10.3390\/biomedicines9080862"},{"issue":"1","key":"1051_CR224","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12920-024-01861-3","volume":"17","author":"A Khavandegar","year":"2024","unstructured":"Khavandegar A, Heidarzadeh A, Angoorani P, Hasani-Ranjbar S, Ejtahed H-S, Larijani B, et al. Adherence to the mediterranean diet can beneficially affect the gut microbiota composition: a systematic review. BMC Med Genom. 2024;17(1):91.","journal-title":"BMC Med Genom"},{"issue":"7346","key":"1051_CR225","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut Microbiome. Nature. 2011;473(7346):174\u201380.","journal-title":"Nature"},{"issue":"11","key":"1051_CR226","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, et al. High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65(11):1812\u201321.","journal-title":"Gut"},{"issue":"2","key":"1051_CR227","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-01223-3","volume":"27","author":"DD Wang","year":"2021","unstructured":"Wang DD, Nguyen LH, Li Y, Yan Y, Ma W, Rinott E, et al. The gut Microbiome modulates the protective association between a mediterranean diet and cardiometabolic disease risk. Nat Med. 2021;27(2):333\u201343.","journal-title":"Nat Med"},{"key":"1051_CR228","doi-asserted-by":"crossref","unstructured":"Rojo-L\u00f3pez MI, Berm\u00fadez-L\u00f3pez M, Castro E, Farr\u00e0s C, Torres G, Pamplona R et al. Low adherence to the mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. Atherosclerosis. 2023;380:117191.","DOI":"10.1016\/j.atherosclerosis.2023.117191"},{"issue":"21","key":"1051_CR229","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3390\/nu16213607","volume":"16","author":"MI Rojo-L\u00f3pez","year":"2024","unstructured":"Rojo-L\u00f3pez MI, Berm\u00fadez-L\u00f3pez M, Castro E, Farr\u00e0s C, Torres G, Pamplona R, et al. Mediterranean diet is a predictor of progression of subclinical atherosclerosis in a mediterranean population: the ILERVAS prospective cohort study. Nutrients. 2024;16(21):3607.","journal-title":"Nutrients"},{"issue":"11","key":"1051_CR230","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1161\/STROKEAHA.120.033214","volume":"52","author":"J Jimenez-Torres","year":"2021","unstructured":"Jimenez-Torres J, Alcal\u00e1-Diaz JF, Torres-Pe\u00f1a JD, Gutierrez-Mariscal FM, Leon-Acu\u00f1a A, G\u00f3mez-Luna P, et al. Mediterranean diet reduces atherosclerosis progression in coronary heart disease: an analysis of the CORDIOPREV randomized controlled trial. Stroke. 2021;52(11):3440\u20139.","journal-title":"Stroke"},{"issue":"2","key":"1051_CR231","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clnu.2020.05.025","volume":"40","author":"M Vitale","year":"2021","unstructured":"Vitale M, Giacco R, Laiola M, Della Pepa G, Luongo D, Mangione A, et al. Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional mediterranean dietary pattern: can SCFAs play a role? Clin Nutr. 2021;40(2):428\u201337.","journal-title":"Clin Nutr"},{"issue":"1","key":"1051_CR232","doi-asserted-by":"publisher","first-page":"2297864","DOI":"10.1080\/19490976.2023.2297864","volume":"16","author":"T Aziz","year":"2024","unstructured":"Aziz T, Hussain N, Hameed Z, Lin L. Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Gut Microbes. 2024;16(1):2297864.","journal-title":"Gut Microbes"},{"issue":"5","key":"1051_CR233","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1152\/ajpendo.00187.2017","volume":"314","author":"ML Battson","year":"2017","unstructured":"Battson ML, Lee DM, Jarrell DK, Hou S, Ecton KE, Weir TL, et al. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction. Am J Physiology-Endocrinology Metabolism. 2017;314(5):E468\u201377.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"1051_CR234","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-019-1611-4","volume":"16","author":"M Morshedi","year":"2019","unstructured":"Morshedi M, Hashemi R, Moazzen S, Sahebkar A, Hosseinifard ES. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review. J Neuroinflammation. 2019;16(1):231.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1051_CR235","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s12602-025-10613-3","volume":"17","author":"SD Bulut","year":"2025","unstructured":"Bulut SD, D\u00f6nda\u015f HA, Celebioglu HU, Sansano JM, D\u00f6nda\u015f NY. Recent insights about probiotics related pharmabiotics in pharmacology: prevention and management of diseases. Probiotics Antimicrob Proteins. 2025;17(4):2262\u201392.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"11","key":"1051_CR236","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1039\/D5FO00384A","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Li T, Dong L, Li Y, Ding H, Wang J, et al. Exploring the lipid-lowering effects of cinnamic acid and cinnamaldehyde from the perspective of the gut microbiota and metabolites. Food Funct. 2025;16(11):4399\u2013414.","journal-title":"Food Funct"},{"key":"1051_CR237","doi-asserted-by":"publisher","first-page":"1243834","DOI":"10.3389\/fimmu.2023.1243834","volume":"14","author":"M Su","year":"2023","unstructured":"Su M, Tang T, Tang W, Long Y, Wang L, Liu M. Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. Front Immunol. 2023;14:1243834.","journal-title":"Front Immunol"},{"issue":"9","key":"1051_CR238","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1021\/acsabm.5c00959","volume":"8","author":"D Sahoo","year":"2025","unstructured":"Sahoo D, Rodriguez E, Nguyen K, Chintapula U. Probiotic bacteria as therapeutics and biohybrid drug carriers: Advances, design Strategies, and future outlook. ACS Appl Bio Mater. 2025;8(9):7513\u201334.","journal-title":"ACS Appl Bio Mater"},{"key":"1051_CR239","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","volume":"13","author":"L He","year":"2019","unstructured":"He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng. 2019;13:58.","journal-title":"J Biol Eng"},{"key":"1051_CR240","doi-asserted-by":"publisher","first-page":"668532","DOI":"10.3389\/fcvm.2021.668532","volume":"8","author":"X Shen","year":"2021","unstructured":"Shen X, Li L, Sun Z, Zang G, Zhang L, Shao C, et al. Gut microbiota and Atherosclerosis-Focusing on the plaque stability. Front Cardiovasc Med. 2021;8:668532.","journal-title":"Front Cardiovasc Med"},{"issue":"17","key":"1051_CR241","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.7150\/thno.76002","volume":"12","author":"CJ Lin","year":"2022","unstructured":"Lin CJ, Cheng YC, Chen HC, Chao YK, Nicholson MW, Yen ECL, et al. Commensal gut microbiota-derived acetate and propionate enhance heart adaptation in response to cardiac pressure overload in mice. Theranostics. 2022;12(17):7319\u201334.","journal-title":"Theranostics"},{"issue":"4","key":"1051_CR242","doi-asserted-by":"publisher","first-page":"e1900797","DOI":"10.1002\/mnfr.201900797","volume":"64","author":"VL O\u2019Morain","year":"2020","unstructured":"O\u2019Morain VL, Ramji DP. The potential of probiotics in the prevention and treatment of atherosclerosis. Mol Nutr Food Res. 2020;64(4):e1900797.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"1051_CR243","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10408398.2011.579361","volume":"54","author":"B Ebel","year":"2014","unstructured":"Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P, et al. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr. 2014;54(2):175\u201389.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"1051_CR244","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1038\/s41598-017-02889-5","volume":"7","author":"DR Michael","year":"2017","unstructured":"Michael DR, Davies TS, Moss JWE, Calvente DL, Ramji DP, Marchesi JR, et al. The anti-cholesterolaemic effect of a consortium of probiotics: an acute study in C57BL\/6J mice. Sci Rep. 2017;7(1):2883.","journal-title":"Sci Rep"},{"issue":"3","key":"1051_CR245","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","volume":"7","author":"XT Gan","year":"2014","unstructured":"Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014;7(3):491\u20139.","journal-title":"Circ Heart Fail"},{"issue":"22","key":"1051_CR246","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138(22):2486\u201398.","journal-title":"Circulation"},{"issue":"1","key":"1051_CR247","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12937-021-00703-7","volume":"20","author":"J Moludi","year":"2021","unstructured":"Moludi J, Kafil HS, Qaisar SA, Gholizadeh P, Alizadeh M, Vayghyan HJ. Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutr J. 2021;20(1):47.","journal-title":"Nutr J"},{"issue":"4","key":"1051_CR248","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/jam.15058","volume":"131","author":"A Tarrah","year":"2021","unstructured":"Tarrah A, Dos Santos Cruz BC, Sousa Dias R, da Silva Duarte V, Pakroo S, Licursi de Oliveira L, et al. Lactobacillus paracasei DTA81, a cholesterol-lowering strain having Immunomodulatory activity, reveals gut microbiota regulation capability in BALB\/c mice receiving high-fat diet. J Appl Microbiol. 2021;131(4):1942\u201357.","journal-title":"J Appl Microbiol"},{"issue":"2","key":"1051_CR249","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.clnu.2017.02.015","volume":"37","author":"F Hendijani","year":"2018","unstructured":"Hendijani F, Akbari V. Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis. Clin Nutr. 2018;37(2):532\u201341.","journal-title":"Clin Nutr"},{"issue":"4","key":"1051_CR250","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11906-017-0723-4","volume":"19","author":"I Robles-Vera","year":"2017","unstructured":"Robles-Vera I, Toral M, Romero M, Jim\u00e9nez R, S\u00e1nchez M, P\u00e9rez-Vizca\u00edno F, et al. Antihypertensive effects of probiotics. Curr Hypertens Rep. 2017;19(4):26.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"1051_CR251","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.numecd.2022.09.005","volume":"33","author":"M Zarezadeh","year":"2023","unstructured":"Zarezadeh M, Musazadeh V, Ghalichi F, Kavyani Z, Nasernia R, Parang M, et al. Effects of probiotics supplementation on blood pressure: an umbrella meta-analysis of randomized controlled trials. Nutr Metabolism Cardiovasc Dis. 2023;33(2):275\u201386.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"1051_CR252","doi-asserted-by":"publisher","first-page":"110941","DOI":"10.1016\/j.nut.2020.110941","volume":"79\u201380","author":"X Liang","year":"2020","unstructured":"Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, et al., et al. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutrition. 2020;79\u201380:110941.","journal-title":"Nutrition"},{"issue":"9","key":"1051_CR253","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.118.313565","volume":"123","author":"M Malik","year":"2018","unstructured":"Malik M, Suboc TM, Tyagi S, Salzman N, Wang J, Ying R, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123(9):1091\u2013102.","journal-title":"Circ Res"},{"key":"1051_CR254","doi-asserted-by":"publisher","first-page":"107963","DOI":"10.1016\/j.micpath.2025.107963","volume":"208","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Khoshroo N, Tafti P, Akbari Moghadam M, Kesharwani P, Sahebkar A. Exploring regional variations in probiotics: implications for efficacy and application. Microb Pathog. 2025;208:107963.","journal-title":"Microb Pathog"},{"issue":"1","key":"1051_CR255","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41598-023-27706-0","volume":"13","author":"B Ma","year":"2023","unstructured":"Ma B, Gavzy SJ, Saxena V, Song Y, Piao W, Lwin HW, et al. Strain-specific alterations in gut Microbiome and host immune responses elicited by tolerogenic bifidobacterium pseudolongum. Sci Rep. 2023;13(1):1023.","journal-title":"Sci Rep"},{"issue":"2","key":"1051_CR256","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/nu12020498","volume":"12","author":"I Azagra-Boronat","year":"2020","unstructured":"Azagra-Boronat I, Massot-Cladera M, Knipping K, Garssen J, Ben Amor K, Knol J, et al. Strain-specific probiotic properties of bifidobacteria and lactobacilli for the prevention of diarrhea caused by rotavirus in a preclinical model. Nutrients. 2020;12(2):498.","journal-title":"Nutrients"},{"issue":"8","key":"1051_CR257","doi-asserted-by":"publisher","first-page":"e043054","DOI":"10.1136\/bmjopen-2020-043054","volume":"11","author":"C Goodman","year":"2021","unstructured":"Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021;11(8):e043054.","journal-title":"BMJ Open"},{"key":"1051_CR258","doi-asserted-by":"publisher","first-page":"766401","DOI":"10.3389\/fimmu.2021.766401","volume":"12","author":"C Shan","year":"2021","unstructured":"Shan C, Li M, Liu Z, Xu R, Qiao F, Du Z-Y, et al. Pediococcus Pentosaceus enhances host resistance against pathogen by increasing IL-1\u03b2 production: Understanding probiotic effectiveness and administration duration. Front Immunol. 2021;12:766401.","journal-title":"Front Immunol"},{"key":"1051_CR259","first-page":"1","volume":"7","author":"G Gibson","year":"2010","unstructured":"Gibson G, Scott K, Rastall R, Tuohy K, Hotchkiss A, Dubert-Ferrandon A, et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bulletin: Funct Foods. 2010;7:1\u201319.","journal-title":"Food Sci Technol Bulletin: Funct Foods"},{"issue":"1","key":"1051_CR260","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.foodres.2008.09.001","volume":"42","author":"Y Wang","year":"2009","unstructured":"Wang Y, Prebiotics. Present and future in food science and technology. Food Res Int. 2009;42(1):8\u201312.","journal-title":"Food Res Int"},{"issue":"7","key":"1051_CR261","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1002\/fsn3.4142","volume":"12","author":"F Ghanbari","year":"2024","unstructured":"Ghanbari F, Hasani S, Aghili ZS, Asgary S. The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review. Food Sci Nutr. 2024;12(7):4569\u201380.","journal-title":"Food Sci Nutr"},{"key":"1051_CR262","doi-asserted-by":"crossref","unstructured":"Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021;13(8):2878.","DOI":"10.3390\/nu13082878"},{"key":"1051_CR263","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ctim.2015.12.010","volume":"24","author":"P Dehghan","year":"2016","unstructured":"Dehghan P, Farhangi MA, Tavakoli F, Aliasgarzadeh A, Akbari AM. Impact of prebiotic supplementation on T-cell subsets and their related cytokines, anthropometric features and blood pressure in patients with type 2 diabetes mellitus: A randomized placebo-controlled trial. Complement Ther Med. 2016;24:96\u2013102.","journal-title":"Complement Ther Med"},{"key":"1051_CR264","doi-asserted-by":"crossref","unstructured":"Lai S, Mazzaferro S, Muscaritoli M, Mastroluca D, Testorio M, Perrotta A et al. Prebiotic therapy with inulin associated with low protein diet in chronic kidney disease patients: evaluation of Nutritional, cardiovascular and psychocognitive parameters. Toxins (Basel). 2020;12(6):381","DOI":"10.3390\/toxins12060381"},{"issue":"5","key":"1051_CR265","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.clnu.2014.10.004","volume":"34","author":"BTS Beserra","year":"2015","unstructured":"Beserra BTS, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MGF, Trindade EBSM. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin Nutr. 2015;34(5):845\u201358.","journal-title":"Clin Nutr"},{"issue":"12","key":"1051_CR266","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1136\/gutjnl-2021-325753","volume":"71","author":"E Belda","year":"2022","unstructured":"Belda E, Voland L, Tremaroli V, Falony G, Adriouch S, Assmann KE, et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut. 2022;71(12):2463\u201380.","journal-title":"Gut"},{"issue":"11","key":"1051_CR267","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ismej.2014.63","volume":"8","author":"A Salonen","year":"2014","unstructured":"Salonen A, Lahti L, Saloj\u00e4rvi J, Holtrop G, Korpela K, Duncan SH, et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. Isme J. 2014;8(11):2218\u201330.","journal-title":"Isme J"},{"issue":"4","key":"1051_CR268","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10517-020-04726-8","volume":"168","author":"AA Vlasov","year":"2020","unstructured":"Vlasov AA, Shperling MI, Terkin DA, Bystrova OV, Osipov GA, Salikova SP, et al. Effect of prebiotic complex on gut microbiota and endotoxemia in female rats with modeled heart failure. Bull Exp Biol Med. 2020;168(4):435\u20138.","journal-title":"Bull Exp Biol Med"},{"key":"1051_CR269","doi-asserted-by":"publisher","first-page":"7658052","DOI":"10.1155\/2019\/7658052","volume":"2019","author":"T Jiang","year":"2019","unstructured":"Jiang T, Xing X, Zhang L, Liu Z, Zhao J, Liu X. Chitosan oligosaccharides show protective effects in coronary heart disease by improving antioxidant capacity via the increase in intestinal probiotics. Oxid Med Cell Longev. 2019;2019:7658052.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1051_CR270","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1039\/D3FO04855A","volume":"15","author":"P Yin","year":"2024","unstructured":"Yin P, Yi S, Du T, Zhang C, Yu L, Tian F, et al. Dynamic response of different types of gut microbiota to fructooligosaccharides and inulin. Food Funct. 2024;15(3):1402\u201316.","journal-title":"Food Funct"},{"issue":"2","key":"1051_CR271","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0043-1760865","volume":"36","author":"YW Cheng","year":"2023","unstructured":"Cheng YW, Fischer M. Fecal microbiota transplantation. Clin Colon Rectal Surg. 2023;36(2):151\u20136.","journal-title":"Clin Colon Rectal Surg"},{"issue":"4","key":"1051_CR272","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913\u2013e67.","journal-title":"Gastroenterology"},{"issue":"4","key":"1051_CR273","doi-asserted-by":"publisher","first-page":"E511","DOI":"10.1152\/ajpendo.00471.2017","volume":"315","author":"TT Kim","year":"2018","unstructured":"Kim TT, Parajuli N, Sung MM, Bairwa SC, Levasseur J, Soltys CM, et al. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. Am J Physiol Endocrinol Metab. 2018;315(4):E511\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1051_CR274","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s12276-022-00728-w","volume":"54","author":"ES Kim","year":"2022","unstructured":"Kim ES, Yoon BH, Lee SM, Choi M, Kim EH, Lee BW, et al. Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q\/TNF-related protein 9 genetic deficiency. Exp Mol Med. 2022;54(2):103\u201314.","journal-title":"Exp Mol Med"},{"key":"1051_CR275","doi-asserted-by":"crossref","unstructured":"Hatahet J, Cook TM, Bonomo RR, Elshareif N, Gavini CK, White CR et al. Fecal Microbiome transplantation and tributyrin improves early cardiac dysfunction and modifies the BCAA metabolic pathway in a diet induced pre-HFpEF mouse model. Front Cardiovasc Med. 2023;10:1105581.","DOI":"10.3389\/fcvm.2023.1105581"},{"issue":"4","key":"1051_CR276","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","volume":"11","author":"T Zhang","year":"2020","unstructured":"Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, et al. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11(4):251\u201366.","journal-title":"Protein Cell"},{"key":"1051_CR277","doi-asserted-by":"publisher","first-page":"1044957","DOI":"10.3389\/fcimb.2022.1044957","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Lu XJ, Lin DJ, Chen WJ, Xue XY, Liu T, et al. Washed microbiota transplantation improves patients with metabolic syndrome in South China. Front Cell Infect Microbiol. 2022;12:1044957.","journal-title":"Front Cell Infect Microbiol"},{"key":"1051_CR278","doi-asserted-by":"publisher","first-page":"679624","DOI":"10.3389\/fcimb.2021.679624","volume":"11","author":"HJ Zhong","year":"2021","unstructured":"Zhong HJ, Zeng HL, Cai YL, Zhuang YP, Liou YL, Wu Q, et al. Washed microbiota transplantation lowers blood pressure in patients with hypertension. Front Cell Infect Microbiol. 2021;11:679624.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1051_CR279","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.clinthera.2023.11.015","volume":"46","author":"A Pakmehr","year":"2024","unstructured":"Pakmehr A, Mousavi SM, Ejtahed H-S, Hoseini-Tavassol Z, Siadat SD, Hasani-Ranjbar S, et al. The effect of fecal microbiota transplantation on cardiometabolic risk factors: A systematic review and Meta-Analysis. Clin Ther. 2024;46(2):e87\u2013100.","journal-title":"Clin Ther"},{"issue":"1","key":"1051_CR280","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5217\/ir.2017.15.1.68","volume":"15","author":"S Mizuno","year":"2017","unstructured":"Mizuno S, Nanki K, Matsuoka K, Saigusa K, Ono K, Arai M, et al. Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res. 2017;15(1):68\u201374.","journal-title":"Intest Res"},{"key":"1051_CR281","doi-asserted-by":"publisher","first-page":"103062","DOI":"10.1016\/j.jaut.2023.103062","volume":"141","author":"R Wu","year":"2023","unstructured":"Wu R, Xiong R, Li Y, Chen J, Yan R. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. J Autoimmun. 2023;141:103062.","journal-title":"J Autoimmun"},{"issue":"3","key":"1051_CR282","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/ijmm.2020.4674","volume":"46","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Shui X, Liang Z, Huang Z, Qi Y, He Y, et al. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). Int J Mol Med. 2020;46(3):936\u201348.","journal-title":"Int J Mol Med"},{"issue":"1","key":"1051_CR283","doi-asserted-by":"publisher","first-page":"e0146439","DOI":"10.1371\/journal.pone.0146439","volume":"11","author":"I Rune","year":"2016","unstructured":"Rune I, Rolin B, Larsen C, Nielsen DS, Kanter JE, Bornfeldt KE, et al. Modulating the gut microbiota improves glucose Tolerance, lipoprotein profile and atherosclerotic plaque development in ApoE-Deficient mice. PLoS ONE. 2016;11(1):e0146439.","journal-title":"PLoS ONE"},{"issue":"7","key":"1051_CR284","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/CIRCRESAHA.119.316394","volume":"126","author":"X Yan","year":"2020","unstructured":"Yan X, Jin J, Su X, Yin X, Gao J, Wang X, et al. Intestinal flora modulates blood pressure by regulating the synthesis of Intestinal-Derived corticosterone in high Salt-Induced hypertension. Circ Res. 2020;126(7):839\u201353.","journal-title":"Circ Res"},{"issue":"9","key":"1051_CR285","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41440-022-00921-4","volume":"45","author":"J Kyoung","year":"2022","unstructured":"Kyoung J, Yang T. Depletion of the gut microbiota enhances the blood pressure-lowering effect of captopril: implication of the gut microbiota in resistant hypertension. Hypertens Res. 2022;45(9):1505\u201310.","journal-title":"Hypertens Res"},{"issue":"2","key":"1051_CR286","first-page":"Cd003610","volume":"2","author":"NJ Sethi","year":"2021","unstructured":"Sethi NJ, Safi S, Korang SK, Hr\u00f3bjartsson A, Skoog M, Gluud C, et al. Antibiotics for secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2021;2(2):Cd003610.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1051_CR287","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","volume":"7","author":"H Liu","year":"2019","unstructured":"Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, et al. Alterations in the gut Microbiome and metabolism with coronary artery disease severity. Microbiome. 2019;7(1):68.","journal-title":"Microbiome"},{"issue":"1","key":"1051_CR288","doi-asserted-by":"publisher","first-page":"e0227147","DOI":"10.1371\/journal.pone.0227147","volume":"15","author":"T Toya","year":"2020","unstructured":"Toya T, Corban MT, Marrietta E, Horwath IE, Lerman LO, Murray JA, et al. Coronary artery disease is associated with an altered gut Microbiome composition. PLoS ONE. 2020;15(1):e0227147.","journal-title":"PLoS ONE"},{"issue":"44","key":"1051_CR289","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1093\/eurheartj\/ehaa704","volume":"41","author":"BJH Verhaar","year":"2020","unstructured":"Verhaar BJH, Collard D, Prodan A, Levels JHM, Zwinderman AH, B\u00e4ckhed F, et al. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study. Eur Heart J. 2020;41(44):4259\u201367.","journal-title":"Eur Heart J"},{"key":"1051_CR290","doi-asserted-by":"publisher","first-page":"5587428","DOI":"10.1155\/2021\/5587428","volume":"2021","author":"Z Wang","year":"2021","unstructured":"Wang Z, Cai Z, Ferrari MW, Liu Y, Li C, Zhang T, et al. The correlation between gut microbiota and serum metabolomic in elderly patients with chronic heart failure. Mediators Inflamm. 2021;2021:5587428.","journal-title":"Mediators Inflamm"},{"key":"1051_CR291","doi-asserted-by":"publisher","first-page":"813289","DOI":"10.3389\/fmicb.2021.813289","volume":"12","author":"W Sun","year":"2021","unstructured":"Sun W, Du D, Fu T, Han Y, Li P, Ju H. Alterations of the gut microbiota in patients with severe chronic heart failure. Front Microbiol. 2021;12:813289.","journal-title":"Front Microbiol"},{"key":"1051_CR292","doi-asserted-by":"publisher","first-page":"1076806","DOI":"10.3389\/fcvm.2022.1076806","volume":"9","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Cai B, Sun Y, Deng H, Wang H, Qiao Z. Alteration of the gut microbiota and metabolite Phenylacetylglutamine in patients with severe chronic heart failure. Front Cardiovasc Med. 2022;9:1076806.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1051_CR293","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.123.063914","volume":"148","author":"S Sayols-Baixeras","year":"2023","unstructured":"Sayols-Baixeras S, Dekkers KF, Baldanzi G, J\u00f6nsson D, Hammar U, Lin YT, et al. Streptococcus species abundance in the gut is linked to subclinical coronary atherosclerosis in 8973 participants from the SCAPIS cohort. Circulation. 2023;148(6):459\u201372.","journal-title":"Circulation"},{"key":"1051_CR294","doi-asserted-by":"publisher","first-page":"e15245","DOI":"10.7717\/peerj.15245","volume":"11","author":"Y Dong","year":"2023","unstructured":"Dong Y, Xu R, Chen X, Yang C, Jiang F, Shen Y, et al. Characterization of gut microbiota in adults with coronary atherosclerosis. PeerJ. 2023;11:e15245.","journal-title":"PeerJ"},{"key":"1051_CR295","doi-asserted-by":"publisher","first-page":"117954682312258","DOI":"10.1177\/11795468231225852","volume":"18","author":"A Sato","year":"2024","unstructured":"Sato A, Arai S, Sumi K, Fukamachi H, Miyake S, Ozawa M, et al. Metagenomic analysis of bacterial microflora in dental and atherosclerotic plaques of patients with internal carotid artery stenosis. Clin Med Insights Cardiol. 2024;18:11795468231225852.","journal-title":"Clin Med Insights Cardiol"},{"issue":"6","key":"1051_CR296","doi-asserted-by":"publisher","first-page":"e1900616","DOI":"10.1002\/mnfr.201900616","volume":"64","author":"I Robles-Vera","year":"2020","unstructured":"Robles-Vera I, Toral M, de la Visitaci\u00f3n N, S\u00e1nchez M, G\u00f3mez-Guzm\u00e1n M, Romero M, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of Short-Chain fatty acids. Mol Nutr Food Res. 2020;64(6):e1900616.","journal-title":"Mol Nutr Food Res"},{"issue":"14","key":"1051_CR297","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.1007\/s00253-020-10693-x","volume":"104","author":"A Hassan","year":"2020","unstructured":"Hassan A, Din AU, Zhu Y, Zhang K, Li T, Wang Y, et al. Anti-atherosclerotic effects of Lactobacillus plantarum ATCC 14917 in ApoE(-\/-) mice through modulation of Proinflammatory cytokines and oxidative stress. Appl Microbiol Biotechnol. 2020;104(14):6337\u201350.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1051_CR298","doi-asserted-by":"crossref","unstructured":"Jiang T, Wu H, Yang X, Li Y, Zhang Z, Chen F et al. Lactobacillus mucosae strain promoted by a High-Fiber diet in genetic obese child alleviates lipid metabolism and modifies gut microbiota in ApoE(-\/-) mice on a Western diet. Microorganisms. 2020;8(8):1225.","DOI":"10.3390\/microorganisms8081225"},{"issue":"5","key":"1051_CR299","doi-asserted-by":"publisher","first-page":"H839","DOI":"10.1152\/ajpheart.00278.2021","volume":"321","author":"A Aboulgheit","year":"2021","unstructured":"Aboulgheit A, Karbasiafshar C, Zhang Z, Sabra M, Shi G, Tucker A, et al. Lactobacillus plantarum probiotic induces Nrf2-mediated antioxidant signaling and eNOS expression resulting in improvement of myocardial diastolic function. Am J Physiol Heart Circ Physiol. 2021;321(5):H839\u201349.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"17","key":"1051_CR300","doi-asserted-by":"publisher","first-page":"e2100214","DOI":"10.1002\/mnfr.202100214","volume":"65","author":"VL O\u2019Morain","year":"2021","unstructured":"O\u2019Morain VL, Chan YH, Williams JO, Alotibi R, Alahmadi A, Rodrigues NP, et al. The Lab4P consortium of probiotics attenuates atherosclerosis in LDL receptor deficient mice fed a high fat diet and causes plaque stabilization by inhibiting inflammation and several Pro-Atherogenic processes. Mol Nutr Food Res. 2021;65(17):e2100214.","journal-title":"Mol Nutr Food Res"},{"key":"1051_CR301","doi-asserted-by":"crossref","unstructured":"Wang Q, He Y, Li X, Zhang T, Liang M, Wang G e t al. Lactobacillus reuteri CCFM8631 alleviates hypercholesterolaemia caused by the Paigen atherogenic diet by regulating the gut microbiota. Nutrients. 2022;14(6):1272.","DOI":"10.3390\/nu14061272"},{"issue":"24","key":"1051_CR302","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1007\/s00253-022-12265-7","volume":"106","author":"T Zhai","year":"2022","unstructured":"Zhai T, Ren W, Wang P, Zheng L. Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis. Appl Microbiol Biotechnol. 2022;106(24):8233\u201343.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"1051_CR303","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/1751-7915.14196","volume":"16","author":"XL Wang","year":"2023","unstructured":"Wang XL, Chen WJ, Jin R, Xu X, Wei J, Huang H, et al. Engineered probiotics clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models. Microb Biotechnol. 2023;16(4):799\u2013812.","journal-title":"Microb Biotechnol"},{"key":"1051_CR304","doi-asserted-by":"crossref","unstructured":"Luo X, Han Z, Kong Q, Wang Y, Mou H, Duan X. Clostridium Butyricum prevents dysbiosis and the rise in blood pressure in spontaneously hypertensive rats. Int J Mol Sci. 2023;24(5):4955.","DOI":"10.3390\/ijms24054955"},{"key":"1051_CR305","doi-asserted-by":"crossref","unstructured":"Yang L, Wu Y, Yang J, Li Y, Zhao X, Liang T et al. Lactiplantibacillus plantarum P470 isolated from fermented Chinese chives has the potential to improve in vitro the intestinal microbiota and biological activity in feces of coronary heart disease (CHD) patients. Nutrients. 2024;16(17):2945.","DOI":"10.3390\/nu16172945"},{"key":"1051_CR306","doi-asserted-by":"crossref","unstructured":"Zhu Y, Yin C, Wang Y. Probiotic Enterococcus faecium attenuated atherosclerosis by improving SCFAs associated with gut microbiota in ApoE(-\/-) mice. Bioeng (Basel). 2024;11(10):1033.","DOI":"10.3390\/bioengineering11101033"},{"issue":"1","key":"1051_CR307","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12964-023-01464-y","volume":"22","author":"HT Yang","year":"2024","unstructured":"Yang HT, Jiang ZH, Yang Y, Wu TT, Zheng YY, Ma YT, et al. Faecalibacterium Prausnitzii as a potential antiatherosclerotic microbe. Cell Commun Signal. 2024;22(1):54.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"1051_CR308","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11274-024-04010-1","volume":"40","author":"A Hassan","year":"2024","unstructured":"Hassan A, Luqman A, Zhang K, Ullah M, Din AU, Xiaoling L, et al. Impact of probiotic Lactiplantibacillus plantarum ATCC 14917 on atherosclerotic plaque and its mechanism. World J Microbiol Biotechnol. 2024;40(7):198.","journal-title":"World J Microbiol Biotechnol"},{"key":"1051_CR309","doi-asserted-by":"publisher","first-page":"151417","DOI":"10.1016\/j.bbrc.2025.151417","volume":"751","author":"Y Liu","year":"2025","unstructured":"Liu Y, Bai Z, Yan R, Ma J, Wang L, Li Y, et al. Lactobacillus rhamnosus GG ameliorates atherosclerosis via suppression of oxidative stress and inflammation by reshaping the gut microbiota. Biochem Biophys Res Commun. 2025;751:151417.","journal-title":"Biochem Biophys Res Commun"},{"key":"1051_CR310","doi-asserted-by":"publisher","first-page":"151642","DOI":"10.1016\/j.ijmm.2024.151642","volume":"318","author":"H Liu","year":"2025","unstructured":"Liu H, Ma X, Yang X, Xiao S, Ouyang S, Hu Z, et al. E. coli Nissle 1917 improves gut microbiota composition and serum metabolites to counteract atherosclerosis via the homocitrulline\/Caspase 1\/NLRP3\/GSDMD axis. Int J Med Microbiol. 2025;318:151642.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"1051_CR311","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.clnu.2018.07.017","volume":"38","author":"F Raygan","year":"2019","unstructured":"Raygan F, Ostadmohammadi V, Asemi Z. The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(4):1594\u20138.","journal-title":"Clin Nutr"},{"issue":"7","key":"1051_CR312","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103.","journal-title":"Nat Med"},{"issue":"2","key":"1051_CR313","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12265-020-10052-1","volume":"14","author":"J Moludi","year":"2021","unstructured":"Moludi J, Saiedi S, Ebrahimi B, Alizadeh M, Khajebishak Y, Ghadimi SS. Probiotics supplementation on cardiac remodeling following myocardial infarction: a Single-Center Double-Blind clinical study. J Cardiovasc Transl Res. 2021;14(2):299\u2013307.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"1051_CR314","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12602-020-09728-6","volume":"13","author":"HF Chiu","year":"2021","unstructured":"Chiu HF, Fang CY, Shen YC, Venkatakrishnan K, Wang CK. Efficacy of probiotic milk formula on blood lipid and intestinal function in mild hypercholesterolemic volunteers: A Placebo-control, randomized clinical trial. Probiotics Antimicrob Proteins. 2021;13(3):624\u201332.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"8","key":"1051_CR315","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1136\/gutjnl-2020-323297","volume":"71","author":"A Koopen","year":"2022","unstructured":"Koopen A, Witjes J, Wortelboer K, Majait S, Prodan A, Levin E, et al. Duodenal anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study. Gut. 2022;71(8):1577\u201387.","journal-title":"Gut"},{"issue":"2","key":"1051_CR316","doi-asserted-by":"publisher","first-page":"e0010022","DOI":"10.1128\/msystems.00100-22","volume":"7","author":"B Sun","year":"2022","unstructured":"Sun B, Ma T, Li Y, Yang N, Li B, Zhou X, et al. Bifidobacterium lactis Probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the Gut-Heart\/-Brain axes. mSystems. 2022;7(2):e0010022.","journal-title":"mSystems"},{"issue":"16","key":"1051_CR317","doi-asserted-by":"publisher","first-page":"8448","DOI":"10.1039\/D4FO00535J","volume":"15","author":"M Lee","year":"2024","unstructured":"Lee M, Bok MK, Son K, Lee M, Park H, Yang J, et al. Bifidobacterium lactis IDCC 4301 (B. lactis Fit\u2122) supplementation effects on body fat, serum triglyceride, and adipokine ratio in obese women: a randomized clinical trial. Food Funct. 2024;15(16):8448\u201358.","journal-title":"Food Funct"},{"issue":"1","key":"1051_CR318","doi-asserted-by":"publisher","first-page":"e0317202","DOI":"10.1371\/journal.pone.0317202","volume":"20","author":"W Luangphiphat","year":"2025","unstructured":"Luangphiphat W, Prombutara P, Jamjuree P, Chantarangkul C, Vitheejongjaroen P, Muennarong C, et al. The efficacy of Lacticaseibacillus paracasei MSMC39-1 and bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study. PLoS ONE. 2025;20(1):e0317202.","journal-title":"PLoS ONE"},{"key":"1051_CR319","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.phrs.2018.11.042","volume":"139","author":"XF Hu","year":"2019","unstructured":"Hu XF, Zhang WY, Wen Q, Chen WJ, Wang ZM, Chen J, et al. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol Res. 2019;139:412\u201321.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1051_CR320","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","volume":"69","author":"P de Groot","year":"2020","unstructured":"de Groot P, Scheithauer T, Bakker GJ, Prodan A, Levin E, Khan MT, et al. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut. 2020;69(3):502\u201312.","journal-title":"Gut"},{"issue":"4","key":"1051_CR321","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cgh.2019.07.006","volume":"18","author":"JR Allegretti","year":"2020","unstructured":"Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020;18(4):855\u2013e632.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1051_CR322","doi-asserted-by":"publisher","first-page":"1105581","DOI":"10.3389\/fcvm.2023.1105581","volume":"10","author":"J Hatahet","year":"2023","unstructured":"Hatahet J, Cook TM, Bonomo RR, Elshareif N, Gavini CK, White CR, et al. Fecal Microbiome transplantation and tributyrin improves early cardiac dysfunction and modifies the BCAA metabolic pathway in a diet induced pre-HFpEF mouse model. Front Cardiovasc Med. 2023;10:1105581.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"1051_CR323","doi-asserted-by":"publisher","first-page":"e14260","DOI":"10.1111\/eci.14260","volume":"54","author":"D Lin","year":"2024","unstructured":"Lin D, Hu D, Song Y, He X, Wu L. Long-term efficacy of washed microbiota transplantation in overweight patients. Eur J Clin Invest. 2024;54(10):e14260.","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"1051_CR324","doi-asserted-by":"publisher","first-page":"e00735","DOI":"10.14309\/ctg.0000000000000735","volume":"15","author":"F Liang","year":"2024","unstructured":"Liang F, Song Y, Lin D, He H, Xu J, He X, et al. Washed microbiota transplantation is associated with improved lipid profiles: Long-Term efficacy and safety in an observational cohort from South China. Clin Transl Gastroenterol. 2024;15(7):e00735.","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-025-01051-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:04:27Z","timestamp":1767798267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-025-01051-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":324,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s12986-025-01051-7","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}